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CHAPTER I 
INTRODUCTION 
Cellular membranes play important roles in processes controlling 
cell growth and differentiation ( 1, 2~). This is particularly true for 
the plasma membrane, which represents the site of interaction for other 
cells or extracellular factors such as hormones. Although these plasma 
membrane functions must be dependent on particular membrane component 
organizations and their organizational changes, very little is known 
about molecular details of plasma membrane structure. Considerable 
progress has been made in delineating some features of erythrocyte mem-
brane structure (J-7), but many questions still remain. For more complex 
cells the problem is aggravated by difficulties inherent in the isolation 
of plasma membranes without intracellular membrane contamination (8), 
which makes even an enumeration and quantitation of plasma membrane 
components difficult. 
Plasma membranes are a complex mixture of proteins, glycoproteins, 
neutral lipids, phospholipids and glycolipids, possibly with some poly-
saccharide attached. There is mounting evidence that submembrane 
proteins are also associated with the plasma membrane in its native 
functional state and these structures should be investigated in con-
junction with the plasma membrane. 
Plasma Membrane Isolation and Structure 
The art of plasma membrane isolation has been reviewed by Steck 
1 
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and Wallach (8). Although new membrane isolation techniques have been 
presented since the publication of this review, they generally fall into 
the same two categories considered in the review. In the first case, 
the cell is homogenized in an appropriate medium to release the plasma 
membrane as large fragments, which can be separated from the intracellu-
lar components. In the second case, the cell is burst by rapid 
decompression of an inert gas in a bomb to reduce all of the cell mem-
branes to semipermeable vesicles. In either case the plasma membrane 
must be separated from the internal membranous constituents. This is 
usually achieved by density gradient centrifugation of the homogenates 
or the microsomal vesicles on sucrose or polysaccharide gradients (9), 
Before homogenization membranes are often "stabilized" in order to pre-
vent membrane disruption and to facilitate the isolation of intact 
envelopes. This is achieved by addition of sulhydryl agents, divalent 
cations such as zn++ (10) or borate buffer (11). The basis for the 
stabilization is still uncertain. Other techniques have been developed 
which might be useful in plasma membrane isolation. Roizman and Spear 
(12) have noted the enhanced density gradient sedimentation rate of 
antibody-plasma membrane complexes. Isoelectric focusing has been 
applied to the fractionztion of cellular membranes (13). The use of 
affinity chromatography should also be feasible, since it has been 
applied successfully to the separation of whole cells (14). 
Isolation of plasma membranes from the Sarcoma-180 ascites tumor 
was first reported by Shin and Carraway (15) in 1973, The isolation 
method, which yielded a reasonable preparation of plasma membranes was 
not, however, optimized, nor were any attempts made to understand the 
effects of the various isolation steps on the final isolation method. 
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Two different methods were used, which although not optimal in their 
results, yielded plasma membranes of reasonable purity. The two methods 
differed mainly in the presence or absence of divalent cation (zn++) 
which yield plasma membranes whose polypeptide distribution differs 
primarily by the lack of a group of high molecular weight plasma membrane 
proteins in the cells homogenized in the absence of divalent cation 
(zn++), The authors also described a method for the surface labeling of 
the SA-180 cell with 125r using lactoperoxidase. 
The major difficulty in isolating plasma membranes comes in iden-
tifying the correct fraction after separation has been achieved. 
Identification is usually based on morphology, cholesterol-phospholipid 
ratios (16), sialic acid content (17), presence or absence of specific 
enzyme markers such as 5'-nucleotidase (18-20), immunochemical markers 
(17,21) and covalent chemical labels (22,23,24). The last have seen 
only very limited use (25) outside the red blood cell field. More 
extensive use of immunochemical identification would be expected if 
purified cell surface antigens can be obtained for preparation of anti-
bodies. 
Considerable advances in the conceptualization of membrane struc-
ture have occurred in recent years. The most popular model is the fluid 
mosaic membrane of Singer and Nicolson (26), which envisions proteins 
associated with a lipid bilayer primarily by hydrophobic forces. These 
proteins may be accessible to one surface of the membrane or to both 
surfaces (if extended across the bilayer). Some of the proteins show a 
considerable degree of lateral mobility in the membrane, This has been 
demonstrated with rhodopsin, the immunoglobulins (27) and cell surface 
antigens (28). The topological distribution of lectin receptors can be 
studied by electron microscope techniques. From these it has been 
suggested that the altered distribution of cell surface sites occurs 
because of crosslinking of the mobile components to which lectins (or 
antibodies) are bound to prevent them from distributing randomly. One 
difference between transformed and nontransformed cells appears to be 
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the mobility of the components in the membrane (29). The source of 
these variations in mobility is still unclear. Nicolson and Painter (30) 
have studied the distribution of sialic acid in erythrocyte ghosts and 
have shown that this can be al tared by anti body perturbation of compo:-
nents at the interior surface of the membranes. Thus protein-protein 
interactions within the membrane may play a role in determining the 
mobility of surface components. Unfortunately, the lectin techniques 
do not permit one to distinguish which components (or even what kind of 
components --- glycoproteins or glycolipid) are under observation. 
More specific studies, e.g. with rhodopsin or immunoglobulins, may 
relate to particular cellular phenomena that are not general for all 
membrane components. Singer (31) has recently reviewed the general 
aspects of membrane structure, particularly the fluid mosaic model, 
which relate to immunological properties of cells and to immune responses. 
Cell Surface Properties 
The importance of the cell surf ace to the control of cellular 
activities is widely recognized. Cell-cell interactions which are 
obviously important to cell aggregation and tissue formation are 
mediated at the cell surface. Contact inhibition or density-dependent 
growth is an example of control of cell growth by cell interactions. 
The action of some hormones on cellular activity has been shown to be 
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initiated at the cell surface (32). The association of cancer with 
changes in cell surface properties has been well established, Altera-
tions in the adhesiveness of cancer cells have been recognized for some 
time (33). Electrophoretic mobility, antigenicity and permeability 
changes are all indicative of significant differences in the cell mem-
brane (17). Investigations of cultured cells transformed with oncogenic 
viruses have been quite fruitful for the detection of membrane changes, 
The presence of carbohydrates at the mammalian cell surface can be 
demonstrated by a number of techniques, Electron microscopists often 
refer to the "fuzzy coat" (34), which is rich in carbohydrates. Proteol-
ysis of mammalian cells releases glycopeptides (35,36), The function of 
cell surface carbohydrates is largely obscure. Recently Pricer and 
Ashwell (37) have shown that removal of sialic acid from liver plasma 
membranes decreases their ability to bind circulating glycoproteins which 
are destroyed in the liver, Thus the carbohydrate of the liver cell 
surface may be involved in recognition of the circulating glycoproteins. 
Cuatrecasas and Illiano (38) have shown that sialic acid removal from fat 
cells results in enhanced glucose transport and loss of the effects of 
insulin on glucose transport and lipolysis, even though the binding of 
insulin is unaffected. The question must be raised whether the glyco-
protein plays a direct role in these processes or whether it has a 
structural role of such importance that alteration of its conformation 
by sialic acid removal results in perturbation of the activities of other 
membrane components. Cell surface carbohydrate has also been implicated 
in cell adhesion or cell-cell aggregation (39). Changes in cell surface 
carbohydrates have been noted after treatment of cultured mammalian cells 
with oncogenic viruses. These changes are manifested as variation in 
6 
glycolipid composition (40-42) and agglutinability by plant phytohemag-
glutinins (4J,44), which bind specifically to carbohydrates. Cells 
which have been released from "contact inhibition" by viral transforma-
tion show a restoration of the "contact inhibition" after treatment with 
monovalent plant agglutinins (45). Protease treatment of normal cells 
mimics viral transformation in that it also renders the cells aggluti-
nable by plant lectins (4J). Recent experiments with ferritin-labeled 
agglutinins have shown that the transformation or proteolysis results in 
an altered distribution of the agglutinin binding sites on the cell 
membranes rather than or as well as an increased number of agglutinin 
receptor sites (46). Warren, Glick and coworkers (47) have demonstrated 
differences in glycopeptides from normal and transformed cultured cells. 
The differences are manifested by molecular weight differences in the 
glycopeptides which appear to be related to a difference in their 
sialic acid contents and the presence of sialyl transferase. 
High Molecular Weight Plasma 
Membrane Polypeptides 
The high molecular weight (HMW) polypeptides will be defined for 
this presentation as polypeptides having apparent molecular weights 
greater than 150,000 and showing little or no carbohydrate by gross 
analytical or staining procedures. The latter qualification is made to 
exclude highly glycosylated glycoproteins which also may have high 
apparent molecular weights. The primary technique for demonstrating 
these species has been sodium dodecyl sulfate (SDS) electrophoresis, a 
method whicli has some drawbacks (48-50), but which has contributed 
enormously to progress in membrane studies. HMW polypeptides have 
been noted for plasma membranes isolated from erythrocytes (48,50-53), 
BHK and L Cells (54), Sarcoma-180 ascites tumor cells (15) and rat 
kidney or liver (55). Results from other workers using different cell 
types (55) indicate that the HMW polypeptides are more characteristic 
of plasma membranes than of internal membranes of the cell. However, 
the association of these polypeptides with the plasma membrane is also 
dependent on membrane isolation conditions (15), so they might not be 
observed in all cases. With the exception of the erythrocyte membrane 
protein spectrin, which will be discussed in the next section, the 
functions of these proteins have not been described. 
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The question of whether these polypeptides are single, continuous 
sequences of amino acids has also not been adequately answered. The 
possibility of covalent crosslinking between individual amino acid 
residues on separate polypeptide chains cannot be ruled out. Such links 
occur in collagen (56), fibrin (57) and other structural molecules. The 
presence of such links in membrane proteins has been suggested by 
Brickbirkler, et al. (58). It is less likely that the HMW polypeptides 
result from noncovalent interactions because of their behavior in 
denaturing media (52), although this possibility has been suggested by 
Dunn and Maddy (59). 
Spectrin 
The only HMW membrane protein which has been characterized to a 
significant extent is spectrin of the erythrocyte membrane. The protein 
was originally isolated and named by Marchesi and Steers (53), who 
showed that it formed coiled filaments when incubated with ATP and ca++ 
or Mg++. The same protein was also isolated by Clarke (60), who called 
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it tektin A. The protein is present in erythrocyte ghosts from all 
species examined (61), and can be solubilized by dialysis or incubation 
of the membranes in low ionic strength buffers. EDTA or ATP may be 
included to aid in solubilization. The protein contains two polypeptide 
chains with molecular weights of about 200,000 and 220,000 as determined 
by SDS electrophoresis (62) or guanidine hydrocholoride chromatography 
(53}. Dunn and Maddy (59) have recently suggested that these polypep-
tides are comprised of subunits of 40,000 based on a combination of 
electrophoresis and chromatography. This leaves the molecular nature 
of these polypeptides still somewhat uncertain until careful characteri-
zation studies are finished. Physical measurements suggest that the 
protein exists in a rod-like form and has limited solubility with 
increased ionic strength, divalent cation or decreased pH (60). Cross-
linking studies indicate that the 200,000 and 220,000 units are present 
as a dimer in the protein (60), which then can be polymerized or can 
exist in the membrane in higher molecular weight forms (63). 
When erythrocyte membranes are extracted with EDTA, a smaller 
polypeptide (MW 45,000 as determined by SDS electrophoresis) is eluted 
along with the spectrin {48,50). In some studies on spectrin it is 
difficult to determine whether this material was present in the prepara-
tions. The polypeptide sizes of the eluted materials are very similar 
to those observed from myosin and actin of muscle. In fact Guidotti (64) 
has suggested that these polypeptides represent an "erythrocyte actomy-
osin" which serves as an underlying network to support the structure of 
the membrane. Evidence to support the similarity to actomyosin is 
rather sparse, particularly since the physical properties of spectrin 
appear to be quite disparate from those of myosin. A low ATPase activity 
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(65) has been associated with spectrin extracts, In addition the lower 
MW polypeptide (200,000) is rather specifically phosphorylated by a mem-
brane kinase (66), The question which remains in this field is whether 
there are actin-like or myosin-like molecules which perform purely struc-
tural roles in cells. 
The association of spectrin with other molecules in the erythrocyte 
membrane may be of great importance to the membrane structure. Juliano, 
et al., (67) have demonstrated an interaction between spectrin and phos-
~ ~ 
pholipid monolayers or vesicles, Of even greater interest are the 
studies of Nicolson and Painter (30), who showed that antispectrin 
antibody sequestered inside ghosts will cause clustering of sialic acid 
residues at the cell surface, This implies an interaction between the 
spectrin and the membrane glycoprotein, which must span the bilayer. 
Such an interaction could be important as part of a transducing system 
for relaying signals from the exterior of the cell (glycoprotein) to 
the interior (spectrin). 
The Effect of Proteolysis on Cells 
Mild proteolysis of cultured fibroblasts causes changes that are 
similar, but not necessarily identical, to those which occur during cell 
transformation (68). Included among these are alterations in cell mor-
phology (69), lectin agglutinability (70), cell surface distribution of 
lectin receptors (71), growth rate (72), and the presence of a surface 
protein detected by lactoperoxidase (73), The presence of plasminogen 
activating factors in transformed cells (74), has led to the suggestion 
that proteolysis may be directly involved in fibroblast transformation, 
Although this hypothesis may not be correct (75), the action of proteases 
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on fibroblasts is certainly of interest because of their multitudinous 
effects on cellular phenomena. In particular the effects of proteolysis 
on cell morphology and lectin receptors suggest that alterations in the 
cell cytoskeleton may be occurring (68). Shin and Carraway recently 
described a set of membrane associated polypeptides which may play a 
role in membrane stabilization and cell shape (76), 
Immunology of Tumors 
It is now generally accepted that most tumors in animals as well as 
man have tumor-specific antigens and/or tumor-associated antigens (TSA) 
the latter of which may also be found in small amounts on certain normal 
tissues (77-81). In addition, most investigators agree that the host's 
immune system plays a major role in the defense against neoplasms (80, 
82-85), Because of the large number of expressed and potentially 
expressed antigenic determinants the immunogenicity of the cell surface 
is extremely complex (81). It is now apparent that certain tumors 
(virus induced) express some cross-reacting TSA's as well as possessing 
distinct nonicrossreacting antigenic components. In contrast, tumors 
induced by a variety of chemical or physical agents appear to possess 
individually specific TSA's that do not cross-protect against similar 
tumors induced in other syngeneic animals with the identical carcinogens 
(81). 
The primary goal of immunotherapy is to utilize the host's immune 
system to prevent manifestation of the tumor by specifically destroying 
all neoplastic cells even though these cells are disseminated throughout 
the host's body. Surgery, radiotherapy and chemotherapy are all vital 
techniques required to reduce tumor burden, but none of theses has 
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sufficient specificity to recognize and discriminately destroy widely 
distributed metastatic cells. Evidence indicates that tumor destruction 
can be accomplished by immunization with modified tumor cells, whose 
surfaces have been altered to enhance tumor specific immunogenicity with-
out provoking autoimmune rejection of normal host tissue (86,87). For 
example, immunization has been successful in several tumor-host systems 
employing whole tumor cells which have been modified by repeated freeze 
thawing or neuraminidase treatment. Alternatively cells can be injected 
into the animal mixed with a "non-specific" immune stimulant such as 
bacillus Calmette-Guerin (88-91). More recent evidence has shown that 
sulfhydxyl modifying agents (iodoacetamide) can enhance tumor cell 
immunogenicity in certain tumor-host systems (92). These findings 
certainly encourage the notion that efficient and effective immunizing 
agents do exist and can be obtained through suitable manipulation. 
In conjunction with the search for superior immunizing agents one 
must also consider the immunological capabilities of the host prior to 
tumor development (normal status), during active tumor growth and at 
different times following anticancer therapy. Many aspects of the 
immunological scheme a.re as yet only partially resolved. The humoral 
and cell-mediated components, once believed to be separate and rather 
independent faculties of the immune system, now appear to vary in their 
degree of interaction from nearly independent activity against some 
types os stimulation to very close interdependence in reaction to other 
stimuli (80,81,84,85,92). In mice, once the tumor cell population 
reaches a mass of between 103 and 104 cells it appears to be sufficiently 
large to nullify those immunological responses of the host capable of 
inhibiting tumor growth (81,91). Many investigators now believe that 
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autosolubilized antigens, mostly of fetal origin, are released from the 
tumor cell. These antigens, free in circulation, are then able to inter-
act with the host's lymphoid cells causing the loss of killer activity, 
These soluble antigens may also stimulate the production of specific 
immunoglobulins which apparently cover the tumor surface and protect it 
from immune destruction (80,81,85), Tumor burden, therefore, must be 
reduced below this nullifying level to allow immunotherapy to proceed. 
Therefore, surgery, radiotherapy or chemotherapy are required to reduce 
tumor burden but they must be timed correctly to allow regain of immune 
responsiveness of the host (94,95), Using chemotherapy, for example, 
the time of recovery of immunocompetence for any given host depends on 
the drug and its dosage schedule employed (96), At different times 
following administration of BCNU to mice with on going L-1210 leukemia 
infections, Kollmorgen found 36 hours between chemotherapy and immuno-
therapy optimal (91). This means that therapeutic protocols for each 
technique and agent employed to reduce tumor burden must be evaluated in 
a given tumor~host system prior to practical testing of immunotherapeutic 
agents and techniques. As complex as the testing program appears, the 
success in those few systems developed is encouraging. 
CHAPTER II 
METHODS 
Growth and Isolation of Cells 
Sarcoma-180 Ascites Tumor 
Sarcoma-180 ascites tumor cells maintained at this university since 
1965 were transferred by weekly intraperitoneal injection of approximate-
ly 1x105 cells in 0,1 ml of Hepes balanced salts (97) (RBS) in COBS 
albino mice (Ham/ICR) of both sexes. After 7 days, approximately 8x107 
cells were recovered from the peritoneal cavity of the mouse by aspira-
tioni and washed four times with ice cold Hepes balanced salts and 
centrifuged at 210g•min (750 rpm x 3 min in a Sorvall SS-34 head). 
Sarcoma-180 in vitro Grown Cells 
Sarcoma-180 (CCRF S-180) CCL8, purchased from the American Type 
Culture Collection Cell Respository in the 88th passage, was grown in 
milk dilution bottles with McCoy's 5A modified medium + 10% calf serum 
(98). Just prior to reaching confluency, the monolayer was scraped from 
the bottle with a rubber policeman and washed four times in ice cold RBS 
and centrifuged at 810g0 min (2000 rpm x 3 min in a Sorvall SS-34 head). 
13762 MAT 
The 13762 MAT (Mammary Ascites Tumor), obtained from the Mason 
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Research Institute Tumor Bank (Worcester, Massachusetts) was maintained 
in Fischer 344 strain females 40-45 days old by intraperitoneal injection 
of 0,2 to 0,3 ml of ascites fluid from rats 10 days postimplantation, 
After 6-10 days, the cells were removed from the peritoneal cavity by 
aspiration and washed three times in ice cold RBS and centrifuged at 
810g•min (2000 rpm x 3 min in Sorvall SS-34 head), 
L-1210 Leukemia 
L-1210 acute lymphoblastic leukemia, first described by Law, et al., 
was obtained from Dr. Kollmorgen, Oklahoma University Health Sciences 
Center (Oklahoma City, Oklahoma) and maintained by intraperitoneal injec-
tion of 1x103 cells in 0,1 ml of RBS into BDF1 mice of both sexes, After 
5-6 days, the cells were removed from the peritoneal cavity by aspiration 
and washed four times in ice cold RBS and centrifuged 810g.min (2000 rpm 
x 3 min in a Sorvall SS-34 head), 
Fetal Mouse Fibroblast in vitro Grown Cells 
In vitro grown fetal mouse fibroblast cells (LM) were grown on 
medium-199 plus 10% calf serum (99) in milk dilution bottles. Cells 
were harvested using a rubber-policeman, washed four times with Hepes 
and 104 cells injected (i.p.) per animal. Fresh cells were prepared for 
each day of injections. 
Plasma Membrane Isolation 
Isolation of Plasma Membranes from the 
Sarcoma-180 Ascites Tumor 
Isolation by a Membrane Stabilization Method 
Washed ascites cells (SA-180) were suspended in 10 volumes of ice 
cold 40 mM Tris (pH 7.4) and the cells allowed to swell for three min-
utes. The swollen cells were then centrifuged 1446g·min (2000 rpm x 3 
min in a SS-34 head). This procedure hemolyzes erythrocytes and leaves 
ghosts in the supernatant. The pellet of washed, swollen cells was 
suspended in 10 volumes of 1 mM ZnCl2 at 25° C. for 15 minutes, then 
cooled on ice for an additional 15 minutes. The cells, which appeared 
swollen, but intact under phase contrast microscopy, were then homogen-
ized by 15-20 strokes of a Dounce homogenizer fitted with a tight pestle 
until most of the cells appeared ruptured and their membranes were visi-
ble as large sheets and intact envelopes. Nuclei were not ruptured as 
judged by comparisons of photomicrographs and cell vs. nuclei counts 
made after each stroke, The homogenate was diluted with an equal volume 
of 40 mM Tris (pH 7.4) and centrifuged 210g•min in a swinging bucket 
head (750 rpm x 3 min in a Sorvall HB-4 head), a step which pellets 
nuclei and whole cells, but leaves plasma membranes in the supernatant. 
The supernatant was then decanted into a new centrifuge tube and centri-
fuged 4820g•min (2000 rpm x 10 min in a Sorvall HB-4 head) to pellet the 
plasma membranes and a few contaminating nuclei. The'pellet was washed 
once more in 40 mM Tris (pH 7.4) and centrifuged 4820g.min (2000 rpm x 10 
min in a Sorvall HB-4 head). 
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Purification by Sucrose Density Gradient. The washed pellet was 
diluted in 40 rnM Tris (pH 7.4) and layered on a discontinuous sucrose 
gradient composed of 8 mls each of 40, 45, 50, 55% (w/w) sucrose (deter-
mined by refractive index) in 20 rnM Tris (pH 7.4) and centrifuged using 
Model L-5 65 Beckman ultracentrifuge in a SW-27 head at 15,000 rpm for 
60 minutes at 4° C. (1,788 x 106g.min). Bands at the 40-45% (B2) and 
45/5fYfo (BJ) interfaces contained plasma membrane envelopes free of nuclei 
with little particulate material. These bands were removed either with 
a bent needle or ISCO Density Gradient Fractionator equipped with O.D. 
Monitor (O.D. 405) and syringe pump. The membranes were washed three 
times in 40 rnM Tris (pH 7.4) and centrifuged 4820g•min. HBS could be 
substituted at this step with no detectable changes in the membrane, 
Purification by the Two-Phase Method of Brunette and Till. The 
washed pellet of crude plasma membranes could alternately be purified by 
partition between two immiscible phases composed of dextran (Dextran 
T500 Pharmacia Uppsala, Sweden), and polyethylene glycol (Carbowax 6000 
Applied Sciences Laboratories, Inc., State College, Pa) polymers in a 
phosphate buffer (pH 6.5) with 1 rnM ZnCl2. The pellet was suspended in 
four volumes of upper phase, mixed with four volumes of lower phase and 
centrifuged 1.2 x 105g•min (10,000 rpm x 10 min in a Sorvall HB-4 head) 
in a swinging bucket head to separate the two phases. The interface 
band was further purified by repeating the two-phase separation. The 
interface band, which appeared to be composed of large plasma membrane 
fragments, was washed four times in either HBS or 40 rnM Tris (pH 7.4). 
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Isolation by a Microsomal Method 
Washed ascites cells were washed additionally two times in 0.25 M 
sucrose-20 mM Tris (pH 7.4) and suspended in 120 ml of 0.25 M sucrose-
20 mM Tris (pH 7.4). This buffer does not cause the cells to swell 
noticeably. The cells were disrupted on ice using a Sorvall Omni-mixer 
with 50 ml chamber and spinning at 11,000 rpm. Usually 6-8 30 second 
bursts, alternated with 60 second cooling periods were required to swell 
and burst the cells. The cells were observed by phase contrast micro~ 
scopy for loss of plasma membranes from cells and appearance of nuclei. 
Cell vs. nuclei counts showed no breakage of nuclei. Homogenization was 
stopped when about 60% of the cells were disrupted. The homogenate was 
centrifuged 7540g•min (2500 rpm x 10 min in a Sorvall SS-34 head) to 
sediment nuclei and whole cells. The supernatant was saved on ice and 
the pellet resuspended in 50 ml of 0.25 M sucrose-10 mM Tris (pH 7.4), 
and homogenized in the Omni-mixer at 11,000 rpm for 3-4 additional 
bursts, until 50% of these cells were broken with the nuclei remaining 
intact. Use of a small aliquot to determine the point of nuclei break-
ing (6-8 bursts) allowed us to stop short of this event. The homogenate 
was centrifuged 7540g•min and the supernatant combined with that of the 
first homogenization and centrifuged 1.737 x 106g•min (12,000 rpm x 10 
min in a Sorvall SS-34 head) to pellet mitochondria. 
The supernatant was carefully removed and centrifuged 7.222 x 106 
g 0 min (27,000 rpm x 75 min in a SW-27 Beckman head) at 4° C. The pellet 
consisting of membrane microsomes was then fractionated by discontinuous 
sucrose gradient flotation. A discontinuous gradient was formed by 
making the pellet to 40% (w/w) in sucrose with 60% sucrose and layering 
~over the pellet 9 mls each of 36% ( w/w) sucrose, 32% ( w/w) sucrose and 
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8.3% (w/w) sucrose with all solutions made 20 mM in Tris (pH 7.4). The 
gradient was centrifuged to equilibrium (27,000 rpm x 4 hours) and the 
band at the 32-36% (w/w) sucrose interphase removed either with a bent 
needle or ISCO Density gradient fractionator and washed four times in 
40 mM Tris (pH 7.4) by centrifuging 1.2 x 105g 0 min (10,000 rpm x 10 min 
in a SS-34 head). 
Plasma Membrane Isolation from the L-1210 
Leukemia by a Membrane Stabilization Method 
Washed leukemia cells were suspended in 10 volumes of ice cold 40 
mM Tris (pH 7.4) for four minutes and allowed to swell before centrifuging 
1440g.min (2000 rpm x 3 min in a Sorvall SS-34 head), This step increases 
the size of the L-1210 leukemia cells by 1.5 to 2 fold while hemolyzing 
erythrocytes and leaving ghosts in the supernatant. The swelling step 
was repeated one time. The pellet was then suspended in 10 volumes of 
ice cold 1 mM ZnCl2 for three minutes and homogenized 10-15 strokes with 
a Dounce homogenizer fitted with the tight pestle until 80-90% of the 
cells appeared broken by phase contrast microscopy, a step which does 
not break nuclei. The homogenate was then diluted with an equal volume 
of 40 mM Tris and centrifuged, 1.07 x 104g.min (3000 rpm x 10 min in a 
Sorvall SS-34 head). The pellet was then suspended in 10 volumes of 40 
mM Tris (pH 7.4) and centrifuged 813g•min (1500 rpm x 3 min in a Sorvall 
HB-4 head) in a swinging bucket head. This pellets nuclei and whole 
cells, leaving plasma membranes in the supernatant. The plasma membrane 
enriched pellet was washed two times by diluting in 40 mM Tris and 
centrifuging 1.07 x 104g.min. 
The pellet from the plasma membrane enriched fraction was then 
purified by the two-phase method of Brunette and Till (100) consisting 
of Dextran-T500 and Carbowax 6000 a polyethylene glycol polymer, phos-
phate buffer (pH 6.5) and 1 mM ZnCl2. The plasma membrane enriched 
fraction was suspended in 10 original cell volumes of upper phase, and 
10 volumes of lower phase was added. The two phases were separated by 
centrifugation 1.20 x 103g•min (10,000 rpm x 10 min in a HB-4 head), 
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The interface band was removed either by a bent needle or decanted 
and the two-phase separation was repeated. The second two-phase pellet 
was judged free of nuclei and whole cells by phase contrast microscopy 
and was washed four times in 40 mM Tris (pH 7,4) by centrifugation of 
1.07 x 104g.min. 
Plasma Membrane Isolation from the 13762 MAT by 
a Membrane Stabilization Method 
The washed mammary adenocarcinoma cells were suspended in 10 
volumes of ice cold 40 mM Tris (pH 7,4), allowed to swell for four min-
utes at 4° C. and centrifuged 1928g.min (2000 rpm x 4 min in a Sorvall 
SS-34 head), The swelling step was repeated and the second pellet 
yielded swollen tumor cells while hemolyzing erthrocytes and leaving 
their ghosts in the supernatant, The swollen cells were suspended in 
11 volumes of ice cold 1 mM ZnCl2 for two minutes and homogenized by 20 
strokes of a Dounce homogenizer fitted with the tight pestle, until 
about 85% of the cells were broken. The homogenization yields whole 
envelopes and large sheets of plasma membranes. The homogenate was then 
diluted with an equal volume of 40 mM Tris (pH 7,4) and centrifuged 4,7 
x 104g•min (1750 rpm x 10 min in a Sorvall HB-4 head) in a swinging 
bucket head. Exact speed is critical here since 4700g.min leaves plasma 
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membranes in the supernatant whereas 4820g.min pellets them. A Power 
Instruments, Inc. (Skokie, Illinois) Optical Tachometer model B-891 was 
used to set the centrifuge speed for each run. The supernatant was 
decanted and recentrifuged at 2.44 x 105g.min (4500 rpm x 10 min in a 
Sorvall HB-4 head) to pellet plasma membranes. The pellet was washed 
two times by suspending in 40 mM Tris (pH 7.4) and centrifuging 2.44 x 
105g.min. The pellet was then purified by layering it in 40 mM Tris 
(pH 7.4) on a discontinuous sµcrose density gradient composed of 8 ml 
each of 40%, 45%, 50%, 55% (w/w) sucrose in 20 mM Tris (pH 7.4) and 
centrifuging it in a model L-5 65 Beckman ultracentrifuge using a Beck-
man SW-27 head at 15,000 rpm for 60 minutes at 40 c. (1.788 x 106g.min 
ave.). All bands were removed either with a bent needle or ISCO Density 
gradient fractionator and washed two times by suspending in either 40 mM 
Tris (pH 7.4) or HBS and centrifuged 1.20 x 105g.min (10,000 rpm x 10 min 
in a Sorvall SS-34 head). 
Studies on the Structure of the 
S-180 Plasma Membrane 
The Effect of Trypsin on the 
S-180 Plasma Membrane 
Time-Lapse Cinematography of the Effect 
of Trypsin on the S-180 Cell 
Cinematography studies were carried out in a Dvorak-Stotler Control-
led Environment Culture System. S-180 cells suspended in M-199 + 10% 
calf serum were inoculated into the chamber and incubated (inverted) in 
a C02 gas phase incubator at 370 C. for 4 hours to allow the cells to 
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attach to the coverslip. The chamber was then placed onto the microscope 
stage and perfused with M-199 + 10% calf serum at 1 ml/hr. The chamber 
temperature was maintained at 37° C. by a Sage air curtain. 
Photography was performed using phase contrast optics and a 16 mm 
time-lapse system. Sequences were filmed at 15 frames/minute with a 
0.75 second exposure. 
Cells were perfused for 12 hours prior to experimentation to allow 
flattening and characteristic spindle morphology to occur. The culture 
was then filmed for at least 1 hour to record its characteristics as a 
control. Trypsin (10 ug/ml in M-199 minus calf serum) was added by 
flushing the chamber to insure uniform trypsin exposure. Filming was 
continued throughout the process and 15 minutes after trypsin addition, 
the chamber was flushed with normal medium (M-199 + calf) and returned to 
perfusion at 1 ml/hour and filming continued to record changes in cell 
morphology. Control sequences were run in which only M-199 minus calf 
serum without trypsin was used in place of trypsin. These sequences 
showed no change in cell morphology either during or following the 15 
minute M-199 minus calf serum exposure. 
The Effect of Trypsin on the SA-180 Cell 
Five days after implantation, SA-180 ascites cells were aseptically 
removed from the mouse peritoneal cavity, washed three times in Hepes 
balanced salts and once in culture medium-199 at 4° C. The cells were 
resuspended to 1 x 104/ml in M-199, warmed to 37° and trypsin added to 
give O, 0.1, 1.0 and 5.0 ug .of trypsin per ml. The cells were mixed by 
gentle swirling and incubation at 37° C. continued. Control samples 
were kept on ice without trypsin to check for proteases in the 370 C. 
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zero trypsin control. After 15 minutes the reaction was stopped by 
either: 1) adding a 20 fold excess of phenylmethylsulfonylfloride (PMSF) 
in DMSO, and allowing the cells to incubate at 2JO C. for JO minutes 
followed by four washes at 40 C. in HBS, or 2) by adding a 100 fold excess 
of soy trypsin inhibitor (chromagraphically purified) at 40 C., incubating 
for JO minutes then washing four times at 4° C. with HBS. The membranes 
were then isolated by the membrane stabilization two-phase method. 
The Effect of Trypsin on the S-180 Cell 
Sarcoma-180 in vitro grown cells (S-180) were grown in milk dilution 
bottles (glass), with McCoy's 5A modified medium+ 1~ calf serum (A). 
Just prior to reaching confluency the monolayer was scraped from the 
bottle with a rubber policeman, pelleted at low speed and washed three 
times with HBS at 40 C. once in M-199, then suspended to 1 x 104 cell/ml 
in M-199 and trypsinized as described above. 
The Effect of Trypsin on the Isolated 
SA-180 Plasma Membranes 
SA-180 plasma membranes isolated by the membrane stabilization two-
phase procedure were suspended in Hepes balanced salts at J mg/ml. One 
sample was kept at 4o C. to check for membrane proteolysis. The membranes 
were warmed at J7° C. and trypsin added to give O.O, 0.1, 1.0, 5.0, 10.0, 
20.0, 50.0 ug trypsin per ml. The membranes were mixed and incubation 
at J7° C. continued. After 15 minutes, the reaction was stopped by 
adding a 20 fold excess of PMSF in DMSO and allowing the membranes to 
incubate at 2J° C. for JO minutes then washing four times in HBS. The 
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membranes were immediately solubilized in the solubilization buffer and 
boiled. 
Lactoperoxidase Labeling of S-180 
and SA-180 Cells 
S-180 in vitro grown cells grown and harvested as described for 
SA-180 cells were washed four times in Hanks balanced salts (pH 7.4) 
and adjusted to 4 x 107 cells/ml with Hanks. Two ml of the cells were 
added to 1 ml of labeling mixture (0.5 uM lactoperoxidase from bovine 
milk), 10 uM KI, 100 uCi Na125I in Hanks balanced salts (pH 7.4) and 5 
aliquots of 2.3 mM H202 added with stirring each JO seconds for 13 
minutes. At 15 minutes the labeling was stopped by adding 0.5 ml of 
100 mM KI and stirring an additional 10 minutes. The labeled cells were 
washed four times in Hanks balanced salts and membranes isolated by the 
membrane stabilization two-phase method. 
Isolation of Several High Molecular Weight 
Proteins from the SA-180 Plasma Membrane 
A Comparison of Extraction Fluids 
SA-180 plasma membranes isolated by the membrane stabilization two-
phase method and stored frozen were thawed and pipetted into three cen-
trifuge tubes to a final concentration of 14 mg membrane protein per 
tube. The tubes were centrifuged at 4000 rpm x 10 minutes to pellet the 
plasma membranes. The pellets were then resuspended in 20 ml of extrac-
tion fluid: a) distilled deionized water (pH 6.o), b) 1.0 M NaCl, c) 5 
mM glycine, 1 mM EDTA, 5 mM mercaptoethanol pH 9.5 (GEM), vortexed for 
10 seconds and incubated at room temperature (23° c.) for 20 minutes. 
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At this time, the membranes were slightly fragmented as shown by phase 
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contrast microscopy. The extracts were then incubated at 40 C. overnight 
and centrifuged in a SW 25.1 he.ad at 25,000 rpm for 60 minutes at 4° C. 
(5880 x 103g•min). The supernatant from each extract was concentrated 
by pressure dialysis using a Diaflo XM-50 membrane at 40 C. (moleculax 
weight exclusion limit 50,000 MW). The pellets and supernatants were 
examined by SDS 5% acrylamide electrophoresis and stained with coomassie 
blue. 
A Compaxison of Extraction Times 
SA-180 plasma membranes isolated by the membrane stabilization two-
phase method and stored frozen as a pellet {30 mg of membrane protein) 
were extracted with 5 ml of GEM pH 9.4 at 4° a. with stirring for four 
hours. The extract was then centrifuged in a SW 65 head at 100,000 x g 
average for one hour (6.0 x 106g.min). The pellet was resuspended in 
5 ml of GEM pH 9,4 and stirred at 4° a. for an additional 20 hours and 
centrifuged for 6.0 x 106g.min as before. Both supernatants were conoen-
trated by pressure dialysis using a Diaflo XM-50 membrane. The total 
extracted protein was 10 mg or 33% of the original protein. The super-
natants were analyzed by SDS electrophoresis and coomassie blue staining. 
Isolation of the High Molecular Weight Doublet 
SA-180 plasma membrane isolated by the membrane stabilization suc-
rose method, and stored frozen was extracted overnight with GEM pH 9.4 
at 40 c. with stirring and centrifuged in a SS-34 centrifuge head at 
15,000 rpm for 30 minutes (910 x 103g.min), This yielded 22 mg of 
extracted soluble protein. The supernatant was dialyzed against distilled 
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water with four changes and the dialysis centrifuged at 15,000 rpm x 10 
minutes (200 x 103g.min). The supernatant contained 2.0 mg of protein, 
the pellet had 14 mg. The pellet was solubilized in 2 ml of GEM pH 9.4, 
made to 10% sucrose and applied to a 90 cm x 2.5 cm G-200 column and 
eluted with GEM pH 9.4. The void volume (Vo) from the column which 
showed a large A280 absorbance was pooled and dialyzed against distilled 
water overnight and centrifuged at 18,000 rpm for 30 minutes (1200 x 103 
g·min). 
The pellet was analyzed by SDS electrophoresis and coomassie blue 
staining. Part of this pellet was suspended in 6.0 N HCL, evacuated, 
sealed and hydrolyzed at 110° C. for 22 hours (101). The tube was 
opened and the HCL removed by evaporation under vacum. The sample was 
run on a Beckman Model 120 C equipped with an autolab analyzer. 
Ammonium Sulfate Fractionization 
SA-180 plasma membranes isolated by the Zn-2Ph method, stored 
frozen were extracted with GEM pH 9.4 at 4° C. with stirring, centrifuged 
6.0 x 106g.min at 4° C. The supernatant was concentrated using a Diaflo 
XM-50 pressure dialysis at 4° C. The supernatant in GEM was stirred at 
40 C. and powdered ammonium sulfate added to give 0.205 gm/ml (29.4% 
saturation) and centrifuged at 5000 rpm x 20 minutes. The supernatant 
was stirred and made to 0.364 gm/ml (52.2% saturation) and centrifuged 
5000 rpm x 20 minutes. The supernatant was made to 0.5 gm/ml (71.1% 
saturation) and centrifuged 5000 rpm x 20 minutes. The pellets and 
supernatant were dialyzed against distilled water and analyzed by SDS 
acrylamide electrophoresis. 
Sepharose 4B Chromatography under 
Non-Denaturing Conditions 
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SA-180 plasma membranes (32 mg) isolated by the membrane stabiliza-
tion two-phase method, stored frozen, were thawed and extracted with 35 
ml of GEM pH 9.4 overnight at 40 c. and centrifuged 6.0 x 106g.min. The 
supernatant was concentrated by pressure dialysis using a Diaflo XM-50 
membrane to 2 ml and applied to a 90 x 2.5 cm Sepharose 4B column and 
eluted with GEM pH 9,4. Three ml fractions were collected and A280 
determined on a Perkin-Elmer model 220 spectrometer. Void volume (Vo) 
was determined using 12 mg of blue dextran and included volume (Vi) using 
40 mg of 2 mercaptoethanol. 
Sepharose 4B Chromatography under 
Denaturing Conditions 
SA-180 plasma membranes isolated by the membrane stabilization two-
phase method stored frozen, were thawed (46 mg membrane protein) and 
solubilized in 5 ml of 5% SDS, 5 mM EDTA, 50 mM phosphate pH 7,4 by 
placing in boiling water for 10 minutes, made to 4% in mercaptoethanol 
and 02 removed by purging with N2 gas. The solubilized membranes were 
covered, stirred overnight and then applied to a 90 x 2,5 cm Sepharose 
4B column and eluted with 0.05 M Tris pH 7,4 + 0.1% SDS and J ml frac-
tions collected. Protein was monitored as A280 using an ISCO 2A 
column monitor. The major peaks were pooled and concentrated by pressure 
dialysis using a Diaflo chamber using a XM-50 membrane. The pooled 
fractions were analyzed by SDS acrylamide electrophoresis. 
The Use of S-180 Plasma Membranes 
as Anticancer Agents 
Animals for Immunological Testing 
Female Ham/ICR mice, 50 to 55 days of age, were used for each 
experiment following at least one week of isolation in this laboratory. 
The mice were maintained on Purina laboratory chow and tap water ad 
libitum. 
Membrane Isolation 
SA-180 plasma membranes were isolated by the membrane stabilization 
two-phase method. · All isolation procedures were conducted under aseptic 
conditions, either in a dust hood or a laminar flow hood. Membrane 
preparations were used immediately or stored frozen (-30° C.) until use 
(one freeze-thawing had no detectable effect on immunizing potential). 
Human and mouse erythrocyte membranes were prepared as described 
by Carraway and Shin (76). Human blood was obtained from the Dallas 
Community Blood Bank and used within 1 week of withdrawal date. Ham/ICR 
mouse blood was removed from the retroorbital sinus, stored in Alseve±'s 
solution, modified and used within two days of withdrawal. 
l 
Immunization of Mice 
Membrane protein concentrations were determined by the Lowry method 
(102). Samples were suspended in Hepes balanced salts solution to the 
desired protein concentration. Animals were immunized with 0.1 ml i.p./ 
injection of the Hepes-membrane suspension or Hepes solution alone as the 
control. Immunization schedules consisted of 3 injections/week for two 
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weeks with a total of 3.0 gm membrane protein injected or two injections 
per week for three weeks with a total injection of 4.4 mg of membrane 
protein. 
Analytical Procedures 
Enzyme Assays 
Protein was determined by the method of Lowry, et al., (102). 
Inorganic phosphate released during enzyme assays was measured by the 
method of Lazarus (103), except in the final step, phosphomolybdate was 
extracted by mixing the final reaction mixture with one volume of isoamyl 
alcohol. After centrifugation the absorbance of the alcohol phase was 
measured at 740 m , The 5'-nucleotidase and succinate dehydrogenase 
(succinate 2-(p-indophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium 
reductase) were assayed as described by Morre' (104). Glucose-6-phos-
phatase was assayed by the method of Goldfischer (105). 
SDS Acrllamide Gel Electrophoresis 
Membrane samples were dissolved by boiling for 5 minutes in 4% SDS-
1% mercaptoethanol-5 mM EDTA-50 mM phosphate (pH 7.4) at a protein 
concentration of 3-10 mg/ml, and the sample incubated overnight at 37° C. 
One-tenth volume of glycerol-0.01 mg ml bromphenol blue was added and a 
sample 50-300 ug of protein per gel applied to 1 cm gels (concentration 
5%; crosslinker/monomer ratio, 0.026). After a 45 minute prerun to 
remove persulfate, the samples were loaded and the gels were run at 8 m 
amp/gel until the bromphenol blue tracking dye reached the end of the 
gel (5 hours total running time), Gels were stained for protein and 
carbohydrate by the method of Fairbanks, et al., (50). The stained gels 
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were scanned at A560 on a Gilford model 240 single beam spectrophotometer 
equipped with a model 2410 linear gel scanner. 
The molecular weights of the membranes were estimated from a plot 
of the logarithm of molecular weight vs. migration distance for a series 
of standard proteins: ribonuclease, bovine serum albumin,S-galactosidase. 
Electrophoresis of 125I Labeled Membranes 
Plasma membranes were solubilized and electrophoresed as described 
above. Three gels were run, one stained for coomassie blue, one for 
PAS and the other immediately sliced into 2 mm slices with a home-made 
gel slicer. The slices were incubated with 0.5 ml of NCS solubilizer at 
50° C. for 24-48 hours, cooled and 10 ml of Brays liquid scintillation 
cocktail (106) added. The vials were kept at room temperature for 12 
hours, then cooled to 4° C. before counting in Packard Tri-Carb liquid 
scintillation spectrometer (Model 3320, Packard Instrument Co., Downer 
Grove, Illinois). 
CHAPTER III 
RESULTS 
Plasma Membrane Purification 
The methods used to isolate plasma membranes from the 3 lines of 
ascites tumors studied are based on two very different approaches. The 
first is based on homogenization of the cell in 0.25 M sucrose with a 
high speed blender which reduces all of the cellular membranes to semi-
permeable microsomes. The other is based on a stabilization of the cell 
plasma membrane by the divalent metal ion zn++ followed by gentle homo-
genization to yield large fragments of plasma membranes. Each of the 
cell types required modification of the isolation scheme to yield plasma 
membranes of reasonable purity. 
Isolation and Characterization of S-180 
q.nd SA-180 Plasma Membranes 
The isolation of plasma membranes from the Sarcoma-180 ascites 
tumor by the zn+"I- method, shown in Fig. 1, yielded plasma membranes of 
reasonable purity when eiiher the sucrose gradient or the two-phase 
isolation was used, Enzymatic specific activities and relative enrich-
ments for the various fractions are shown in Table I. The location of 
plasma membrane envelopes seen by phase contrast microscopy during the 
isolation protoc~l correlated very well with the location of 5'-nucleo-
tidase, and showed a 23 fold purification over the homogenate value. 
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Figure 1. Membrane Isolation Scheme for the Sarcoma-180 Tumor Using the 
Satbilization Technique 
Details of the isolation procedure are given in the methods section. 
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TABLE I 
ENZYME SPECIFIC ACT.IVITIES AND ENRICHMENT OF MEMBRANE FRACTIONS 
OF SARCOMA-180 ASCITES TUMOR AND IN VITRO SARCOMA-180 
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Values in parentheses are relative specific activities expressed as the 
ratio of the value for the particular fraction to that of the homogenate. 
All specific activities are in µMoles/mg/min. 
Fraction Glucose 6 
Phosphatase 
Succinic INT 
Reductase 
SA-180 Membrane Stabilization Sucrose Method 
Homogenate 
Plasma Membranes 
(Bd 2+3) 
0.1 ( 1) 
0.5 (5) 
SA-180 Microsomal Method 
Homogenate 0.3 ( 1) 
F1 18.1 (60) 
F2 5.2 (17) 
F3 5.2 (17) 
F4 0.2 (0.7) 
Sarcoma-180 In Vitro Line 
Homogenate 
Interface band 
0.2 (1) 
0.5 (2.5) 
2.3 (1) 
LO (o.4) 
7.0 (1) 
8.0 (1.1) 
2.0 (0.3) 
16.0 (2.3) 
4.o (o.6) 
2.0 (1) 
0.1 (0.05) 
5'-Nucleotidase 
0.1 (1) 
2.3 (23) 
0.2 (1) 
0.4 (2.0) 
3.8 (19) 
0.8 (4) 
0.3 ( 1.5) 
0.3 (1) 
5.3 (18) 
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Nuclei were not present as judged by phase contrast microscopy. Succinate 
dehydrogenase, a mitochondrial marker, was reduced to less than the homo-
genate, but there was some glucose-6-phosphatase contamination by the 
sucrose method, indicative of endoplasmic reticulum. The two-phase 
method did not have this enzyme contamination. 
The microsomal preparation shown in Fig. 2, yielded a homogenate in 
which only the nuclei could be distinguished, and all subsequent purifi-
cation steps had to be monitored by marker enzymes. The F2 fraction 
showed a 19 fold enrichment of 5'-nucleotidase over the homogenate value, 
without contamination by succinate dehydroge~ase or nuclei. There was 
apparent contamination with glucose-6-phosphatase, however, The three 
ways of isolating plasma membranes did vary in their yield of membrane 
protein from a comparable number of cells. The two-phase separation 
yielded about 2.5 mg/8 x 107 cells, the sucrose gradient about 1.1 mg/ 
8 x 107 cells and the microsomal method about 0.5 mg/ 8 x 107 cells. 
Because of the increased yield of membranes per cell by the two-phase 
method, this was the only method used to isolate plasma membranes from 
the S-180 in vitro grown cells. Plasma membranes isolated from these 
cells showed a 18 fold purification of 5'-nucleotidase with no succinate 
dehydrogenase or nuclei and low levels of glucose-6-phosphatase. Plasma 
membranes from Sarcoma-180 isolated by various methods were next subjected 
to electrophoresis on 5% acrylamide gels and stained for protein by 
coomassie blue and glycoprotein by the PAS stain. 
When the membrane stabilization sucrose method was compared with 
the microsomal method for SA-180 membranes in Fig. 3, the following 
differences were noted. Membranes isolated by the microsomal method 
had greatly reduced amounts of the three highest molecular weight 
Figure 2. Microsomal Method Isolation Scheme for the Sarcoma-180 Tumor 
---~~~--~~~~~~W-a_s__.hld CellsWash in 0.25 M Sucrose 
SupJrnatant Pellet 
(Washed Cells) 
Suspend in 0.25 M Sucrose 
Homogenize (Omni-Mixer) 
Centrifuge 2500 rpm x 10 min 
Pel et 
(Whole Cells and Nuclei) 
Supernatant 
(Microsomal fraction) 
Repeat Homogenization Step 
Pel et 
(Whole Cells and Nuclei) 
Supernatant 
(Microsomal fraction) 
Comb ned Supernatants 
Centrifuge at 12000 rpm x 10 min 
I 
Pell~e-t~~--~~~~--~~S-u_p_e~rlnatant Centrifuge at 27000 rpm x 75 min 
I Supernatant Pellet 
(Cytoplasm) (Microsomal Membranes) 
9 
32 27,000 rpm for 4 hours 
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Wash band in 40 mM Tris 
F 4 
Figure 3. Gel Scans of Coomassie Blue and Periodate Acid-Schiff stained 
Polyacrylamide Gels of Sarcoma-180 Ascites Tumor Plasma 
Membranes Isolated by the Membrane Stabilization and 
Microsomal Methods 
(A) CB and (B) PAS stains of SA-180 membrane stabilization method 
isolated plasma membranes. (C) CB and (P) PAS stains of SA-180 microsomal 
method isolated plasma membranes. 
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coomassie blue bands (300+, 280, 240) but had almost quantitatively the 
same amount of protein in all other bands, When the glycoprotein patterns 
shown by the PAS stain of SA-180 were compared between the zn++ and 
microsomal method, the microsomal showed a higher apparent molecular 
weight glycoprotein (115 vs. 100 x 10-3) and a low molecular weight 
glycoproteins. When the gel patterns for the S-180 plasma membranes 
were examined the polypeptide distribution was identical to that of the 
SA-180 plasma membrane although there are some minor differences in 
staining intensity. By comparison the periodate-Schiff staining patterns 
show striking differences. The ascites form has a major band near the 
center of the gel plus smaller amounts of staining material near the top 
of the gel and near the bottom. The cultured form seen in Fig, 4, shows 
two major intense (PAS-1 and 2) sharp bands which have barely migrated 
into the gel plus smaller amounts of staining material near the center 
and bottom of the gel. Because of variation in the amount of the high 
molecular weight band during several isolations, plasma membranes were 
isolated from the cell just prior to confluency and two days after the 
cells reached confluency. The cells prior to confluency showed large 
amounts of the high apparent molecular weight glycoprotein, while those 
harvested after confluency were almost devoid of the glycoprotein. 
Isolation and Characterization of L-1210 
Plasma Membranes 
The isolation scheme shown in Fig. 5, stabilizes the L-1210 plasma 
membrane so that whole envelopes and large fragments can be isolated. 
This cell type required two swelling steps and a very short treatment 
with ice cold 1 mM ZnCl2 to allow the disruption of the cell without 
Figure 4. Gel Scans of Coomassie Blue and Periodate-Acid-Schiff Stained 
Polyacrylamide Gels of the in vitro grown Sarcoma-180 Plasma 
Membrane Isolated by the Membrane Stabilization Method 
(A) CB and (B) PAS stains of S-180 plasma membrane from 5% acry~ 
lamide gels run at 8 M Amp/gel for 5 hours. (C) PAS stain of 5% 
acrylamide gel run at 8 M Amp/gel for 10 hours to allow it to migrate 
further into the gel. 
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Figure 5. Membrane Isolation Scheme for the L-1210 Leukemia Using the 
Stabilization Technique 
Details of the isolation are given in the methods section. 
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fragmenting the plasma membranes into vesicles. Table II shows the 
enzyme specific activities of the band at the interphase of the two-
phase system, which was composed of folded whole envelopes and large 
membrane fragments and was judged free of nuclei by phase contrast mic-
roscopy. The band showed a 34 fold purification of 5'-nucleotidase 
without significant contamination by succinate dehydrogenase and glucose-
6-phosphatase. The L-1210 membranes were solubilized and subjected to 
SDS acrylamide electrophoresis. The gel scans shown in Fig. 6, show 19 
polypeptides ranging from 73,000 to 25,000 apparent molecular 
weight. Several high molecular weight proteins can be seen in the PAS 
scan. 
Isolation of Plasma Membranes from the 13762 MAT 
The membrane stabilization method using zn++ shown in Fig. 7, allows 
for the isolation of whole plasma membrane envelopes and large sheets of 
plasma membrane with only low levels of other organelle contamination. 
A series of photomicrographs seen in Fig. 8, shows the isolation proce-
dure. In frame A, the whole cell is seen just after removal from the 
animal. Frame B shows the cell after swelling. The diameter of the cell 
has been seen to increase and some separation of the cytoplasm from the 
plasma membrane is seen. Frame C shows the zn++ treated cell. The 
plasma membrane has a much more pronounced appearance and the cytoplasm 
more granular. Frame D shows the homogenized eel.ls containing whole 
plasma membranes and large sheets. Frame E shows the plasma membrane 
fraction from the sucrose density gradient and Frane F shows one of the 
membranes at higher magnification. The enzyme specific activities and 
enrichment of membrane fractions is shown in Table III. The band at the 
TABLE II 
ENZYME SPECIFIC ACTIVITIES AND ENRICHMENT OF MEMBRANE 
FRACTIONS OF THE L-1210 LEUKEMIA 
Values in parentheses are relative specific activities expressed as the 
ratio of the value for the particular fraction to that of the homogenate. 
All specific activities are in µMoles/mg/min. 
Fraction Glucose 6 
Phosphatase 
Membrane Stabilization Method 
Homogenate 
Two-phase interface 
0.4 (1) 
0.9 (2) 
Succinic INT 
Reductase 
4.3 (1) 
4.3 (1) 
5'-Nucleotidase 
0.2 (1) 
7,9 (34) 
Figure 6. Gel Scans of Coomassie Blue and Periodate-Acid-Schiff Stained 
Polyacrylamide Gel Scans of 1-1210 Plasma Membranes 
(A) CB and (B) PAS stains. 
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Figure 7. Membrane Stabilization Method Isolation Scheme for the 13762 
MAT 
Details of the isolation are given in the methods section. 
----------W-a ... led Cells40 mM Tris 
Sup[rnatant Pellet 
{Hemolyzed RllC) . {swf11en cells) 
ReP,eat Swelling 
SwoLen Cells 
1 mM ZnC12, 4 min at 4° c. 
++ Zn Treated Cells 
Homogenize (Dounce) 
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15000 rpm for 60 min 
at 4° C. 
Wash band in 40 mM Tris 
10 min 
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Figure 8. Photomicrographs of the 1J762 MAT during the Isolation 
Procedure 
Frame (A) shows the whole cell in the peritoneal fluid. Frame (B) 
shows the cell following swelling in 40 mM Tris (pH 7.4). Frame (c) 
shows the cell following treatment with zn++. Frame (D) shows the cell 
after one stroke of homogenization. Frame (E) shows the isolated plasma 
membrane. 
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TABLE III 
ENZYME SPECIFIC ACTIVITIES AND ENRICHMENT OF 
MEMBRANE FRACTIONS OF THE 13762 MAT 
52 
Values in parentheses are relative specific activities expressed as the 
ratio of the value for the particular fraction to that of the homogenate. 
All specific activities are in µMoles/mg/min. 
Fraction Glucose 6 
Phosphatase 
Membrane Stabilization Method 
Homogenate 1.0 (1) 
Cytoplasm 0.9 (0.9) 
Nuclear fraction 0.1 (0.1) 
Bi 0.2 (0.2) 
B2 0~3 (0.3) 
B3 0.5 (0.5) 
B4 8.4 (8.3) 
1. value not determined. 
Succinic INT 
Reductase 
1.5 (1) 
2.0 ( 1.3) 
1.0 (0.7) 
14.8 (9.9) 
2.0 ( 1.3) 
1.9 (1.3) 
N. D. 1 
5'-Nucleotidase 
1.95 (1) 
1.5 (o.8) 
o.6 (0.3) 
22.5 (11.5) 
27.0 (13.5) 
13.5 (6.9) 
10.5 (5.4) 
53 
SDG 40/45% (w/w) interface showed a 13.8 fold enrichment of 5'-nucleo-
tidase over the homogenate. The enzyme proved to correlate well with 
the location of whole membrane envelopes but was not stable on storage 
with time so the assay was run within 10 hours after isolation. The 
same fraction was also free of glucose-6-phosphatase and succinate 
dehydrogenase contamination. The B2 fraction was free of nuclei by 
phase contrast microscopy. This material was next solubilized and 
subjected to SDS acrylamide electrophoresis. The results are shown in 
Fig. 9, The coomassie blue band shows 19 major bands varying from 500+ 
to 28 x 10-3 apparent molecular weight. Three major PAS positive bands 
of high apparent molecular weight and two minor bands were observed 
although molecular weight is very questionable by SDS acrylamide methods. 
The methods described above yield plasma membranes from three different 
tumors reasonably free of other cellular organelles. Table rv shows a 
tabulation of the molecular weights for the polypeptides for all cell 
types. Fig. 10, shows PAS scans for the three cell types showing no 
major similarities in proteins although there are groups of proteins 
with about the same molecular weight. 
Organization of the Sarcoma-180 Plasma Membrane 
The Effect of Trypsin on the Sarcoma-180 
Plasma Membrane 
Mild trypsinization of the cultured S-180 causes pronounced changes 
in cellular morphology as shown by phase contrast time-lapse cinemato-
graphy. Fig. 11, shows the results of trypsin treatment on S-180 cells 
attached to a glass substrate. The sequences begin (A) 4 minutes after 
trypsin treatment in which no morphological changes have yet occurred. 
Figure 9. Gel Scans of Coomassie Blue and Periodate-Acid-Schiff Stained 
Polyacrylamide Gels of the 13762 MAT 
(A) CB and (B) PAS stains. 
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TABLE "IV 
COOMASSIE BLUE (CB) AND PERIODATE SCHIFF (PAS) STAINING PO~JPEPTIDES 
VALUES ARE G"IVEN AS APPARENT MOLECULAR WEIGHTS X 10 
13762, Zn L-1210, Zn 
CB PAS CB PAS 
1 .500 7.50 300 300 
2 300 300 265 293 
3 240 2.50 23.5 290 
4 17.5 210 208 268 
.5 12.5 180 182 
6 120 168 
7 112 13.5 
8 98 122 
9 88 104 
10 81 91 
11 7.5 84 
12 63 72 
13 .56 66 
14 47 .5.5 
1.5 42 47 
16 38 44 
17 33 38 
18 32 31 
19 28 2.5 
-· 
SA-180, Zn 
CB PAS 
JOO 
280 100 
237 7.5 
216 
.5.5 
190 36 
178 
148 
126 
112 
78 
.56 
48 
42 
36 
32 
SA-180 
Microsomal 
CB PAS 
11.5 
237 7.5 
216 
.5.5 
190 
178 
148 
126 
112 
78 
.56 
48 
42 
36 
32 
Figure 10. Gel Scans of Periodate-Schiff Stained Polyacrylamide Gels of 
Several Tumors 
(A) SA-180 membrane stabilization method. (B) SA-180 microsomal 
method. (C) S-180 membrane stabilization method. (D) L-1210 Leukemia. 
(E) 13762 MAT. 
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Figure 11. The Effect of Trypsin on the in vitro Grown Sarcoma-180 
The frames are following trypsin addition, (A) 4 min., (B) 12.5 min., 
(C) 16.J min., (D) 20 min., (E) 8 hours, (F) 20 hours, (G) 24 hours. 
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Frame (B), 12.5 minutes after trypsin addition, shows a number of cells 
that have begun to withdraw their appendages and become rounded. At 
15 minutes the trypsin is removed and the cells are prefused with the 
M-199 + calf serum. Frame (C) shows the cells 16.3 minutes after trypsin 
addition and frame (D); taken at 20 minutes after trypsin addition, shows 
that all the cells are rounded with only minute projections very similar 
to cells undergoing mitosis. 
Frame (E) shows the cells some 8 hours after trypsin treatment and 
some flattening of the cells has begun to take place. This flattening 
and spindle formation continues and in frames (F) and (G), 20 and 24 
hours after trypsin treatment the cells have regained their characteristic 
fibroblast morphology seen in frame (A) and many cells have undergone at 
least ~ne division. 
-1 
I 
Only two or three of the cells in the original 
field became detached from the glass_ and swept away by the perfusion 
medium~ Most of the cells did undergo subsequent division following 
trypsin treatment indicating that the tryptic action,. while able to cause 
a dramatic change in cell morphology, does not cause loss of cell 
viability. 
Because of this effect on cell morphology it was of' interest to 
determine what membrane changes occur at the molecular level. The initial 
observations were made with-the ascites form of the sarcoma-180, since it 
occurs as a single cell stage, facilitating trypsin treatment and mem-
"Prane stabilization two-phase method and subjected to acrylamide gel 
electrophoresis in sodium dodecyl sulfate. The polypeptide and glyco-
protein patterns for trypsinized (5 ug/ml) and untreated samples are 
shown in Fig. 12. As expected, the glycoproteins have been eliminated 
from the patterns by trypsinization, In addition, a group of high 
Figure 12. The Ef'fect of Trypsin on the Sarcoma-180 Ascites Tumor 
Gel scans of Coomassie Blue and Periodate-Acid-Schiff stained poly-
acrylamide gels. SA-180 plasma membranes isolated from control cells 
stained for CB (A) and PAS (B), and (D) SA-180 plasma membranes from 
cells treated with trypsin and stained for CB (C) and PAS. 
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molecular weight polypeptides are not observed in the proteolyzed samples. 
There are no other significant changes in the patterns except for an 
increase in material in the lower molecular weight regions of the gels, 
probably arising from degradation products of the trypsinization, The 
missing polypeptides are the same species that we have suggested are 
involved in membrane "stabilization" during isolation by the method of 
Warren and Glick (10). They are present in the "stabilized" membrane 
sheets or envelopes but not is vesicular membrane preparations. 
Separate studies were performed on the in vitro Sarcoma-180. The 
primary difference between these two cell lines is a difference in sur-
face membrane glycoproteins which are present on the cultured form but 
not on the ascites form. Trypsinization of the cultured cells followed 
by membrane isolation gave similar results to those found with the 
ascites form, but the changes were not quite as dramatic (Fig, 13), The 
glycoproteins are essentially completely removed from the pattern, but 
the high molecular weight polypeptides are shown to be decreased only 
about 7CJfi when staining densities are normalized against smaller poly-
peptides that are unaffected. To establish that the disappearance of 
the three high molecular weight proteins and the glycoproteins was not 
due to extreme susceptibility to cleavage by trypsin isolated SA-180 
plasma membranes were trypsinized. The gels from the experiment in Fig. 
14, show that the high molecular weight component is relatively insensi-
tive and that the glycoproteins are not cleaved except at high trypsin 
concentration. 
To determine if the S-180 PM high apparent molecular weight glyco-
protein doublet was exposed to the outside of the cell, surface labeling 
with lactoperoxidase was performed on the S-180 and SA-180 cells. The 
Figure 13. The Effect of Trypsin on the In Vitro Grown Sarcoma-180 
Gel scans of Coomassie Blue and Periodate-Acid~Schiff stained poly-
acrylamide gels. S-180 plasma membranes isolated from control cells 
stained for CB (A) and PAS (B), and (D) S-180 plasma membranes from 
cells treated with trypsin and stained for CB (C) and PAS. 
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Figure 14. The Effect of Trypsin on the Sarcoma-180 Ascites Tumor Cell 
Isolated Plasma Membrane 
Plasma membranes isolated by the membrane stabilization method were 
trypsionized as described in the methods section. The upper photograph 
is the PAS stained gels, and the lower photograph is the CB stain. 
Trypsin concentrations for each set are; (A) none, (B) 0,1, (C) 1.0, (D) 
5.0, (E) 10.0, (F) 20.0, (G) Ug/ml. ' 
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coomassie blue and PAS patterns are the same as those shown in Fig. 3 
and 4. The labeling profile in Fig. 15 shows the major peak to be in 
the same slice as that of the glycoprotein, there was no coomassie blue 
staining at the origin. The SA-180 pattern is shown also for reference. 
The Isolation of the High Molecular Weight 
Proteins from the Sarcoma-180 Plasma Membrane 
Because of the similarity in molecular weights between the 240, 
220 x 10-3 molecular weight doublet and spectrin the structural protein 
of the red cell, and because the disappearance could be correlated with 
shape changes in the cell, attempts were made to isolate the high molec-
ular weight proteins from the SA-180 PM. Plasma membranes were extracted 
overnight with 1.0 M NaCl and two low ionic strength buffers. Gel pro-
files for the three extracts are shown in Fig. 16. The high ionic 
strength extract showed very little of the high molecular weight proteins 
(300+, 280, 240, 220 x 10-3) in the supernatant of the 1.0 M NaCl extract, 
but several low molecular weight proteins ( >72 x 10-3). The pellet had 
85% of the membrane protein, but was congealed into a gummy pellet, 
which could not be used for further extractions. The two low ionic 
strength extracts showed similar results. A number of high molecular 
weight proteins were partially extracted from the membranes (300+, 280, 
240, 220 x 10-3) along with several lower molecular weight proteins (112, 
78, 56, 48, 36 x 10-3). The GEM buffer extracted less of the lower 
molecular weight proteins and was chosen for further studies. The GEM 
buffer was used to extract PM for 4 hours and the residue extracted an 
additional 20 hours. The two extracts are shown on Fig. 17, and show 
that 13 major are extractable from the membranes. The four-hour extract 
Figure 15. Lactoperoxidase Labeling of Sarcoma-180 Cell 
S-180 cells were labeled with 125r using lactoperoxidase. The plasma 
membranes wer!2~solated, electrophoresed on acrylamide gels, cut into 2 mm 
sections and I counted by liquid scinilization counting. (A) is the 
SA-180 in vivo tumor, (B) is the S-180 in vitro grown cell. 
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Figure 16. Gel Profiles of Membrane Extracts 
(A) 1.0 M NaCl extract, (B) 1.0 M NaCl extracted membrane pellet, 
(C) distilled water extract, (D) distilled water extracted membrane 
pellet, (E) GEM extract, (F) GEM extracted membrane pellet. 
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Figure 17. A comparison of Extraction Times 
SA-180 plasma membranes extracted 0-4 hours (A) and 4-24 hours (B). 
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does not, however, remove all of the extractable high molecular weight 
proteins. Therefore, longer extraction periods were used to obtain 
enough of the extract for subsequent pruification attempts. The 0-4 
hour extract had only the 280, 240 x 10-3 molecular weight bands, pre-
sumable because the small amount of the 220 x 10-3 molecular weight band 
that remains in the membrane is unextractable. 
The G-200 column elution profile (Fig. 18) showed a lar~e void 
volume peak. The gel profile for the extract and Vo peak is shown in 
Fig. 19. The Vo peak contained primarily (<90%) the 240, 220 x 10-3 
molecular weight doublet. Amino acid analysis of the doublet is shown 
in Table V. Comparison of the amino acid composition with that of spec-
trin the 240, 220 x 10-3 molecular weight structural protein of the 
human red blood cell by the method of Marchalonis and Weltman (107) can 
be interpreted as relatedness. The extracted proteins were then sepa-
rated by gel filtration. In an attempt to further purify the high 
molecular weight proteins, the extract was fractionated with ammonium 
sulfate (Fig. 20). The ammonium sulfate fractionation precipitated the 
high molecular weight proteins between 0 and 0.205 gm/ml while leaving 
a large number of the lower molecular weight proteins in solution. This 
increases the amount of the high molecular weight protein in the fraction 
from 20% to 60% of the total protein. 
Gel filtration coiumn chromatography was then investigated to see 
if the soluble proteins could be purified in their native state. 
Attempts to separate the high molecular weight proteins by non-denaturing 
gel filtration chromatography are shown in Fig. 21. The peaks were 
pooled, concentrated by pressure dialysis and electrophoresed as des-
cribed. The first two fractions off of the column both contained the 
Figure 18. G-200 Fractionation of the GEM Extract 
0 
. U') 
·~ 
0 
W) 
0 
. (\J 
0 
-
____ __.~------i.------..__--__,o 
N 
. 
U') 
-0 0 -
. 
0 
8 0 
. 
0 
78 
ci 
~ 
~ 
:J 
z 
w 
CD 
::> 
r-
Figure 19. Purification of the High Molecular Weight SA-180 Doublet 
(A) shows the GEM extract, (B) the G-200 void volume peak. 
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TABLE V 
AMilJO ACID COMPOSITION OF A HIGH MOLECULAR WEIGHT PROTEilJ 
DOUBLE!' FROM THE SA-180 PLASMA MEMBRANE 
Aspartic Acid + Asparagine 
Threonine 
Serine 
Glutamic Acid + Glutamine 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
i Cystine 
SAQ 
SA-1801 
Doublet 
9.57 
5.40 
8.33 
13.92 
3.75 
8.48 
7.99 
4.69 
1.59 
3.51 
9.66 
2.18 
5.06 
6.84 
2.33 
6.73 
N. D. 3 
Spectrin1 
Doublet 
10.43 
4.29 
5.87 
18.03 
2.31 
4.70 
9.12 
4.45 
1.82 
3.65 
12.01 
2.04 
3.25 
6.66 
2.83 
5.92 
1.1 
81 
0.74 
1.23 
6.05 
16.89 
2.07 
14.29 
1.28 
0.06 
0.05 
0.02 
5.52 
0.02 
3.28 
0.03 
0.25 
0.87 
N. D. 
52.65 
1. Values are given as mole % 2 by the method of Marchalonis 2. SA-180 (mole %) - Spectrin (mole %) 
and Weltman (107) 
3. Not determined 
Figure 20. Ammonium Sulfate Fractionation of the GEM Extract 
(A) 30%, (B) 52%, (C) 71% saturation cuts. 
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Figure 21. Sepharose 4B in GEM Fractionation of the GEM Extracted 
Proteins 
Gel (A) is from fraction I, and gel (B) from fraction II. 
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high molecular weight proteins along with several lower molecular weight 
proteins. The great difference in molecular weight of the polypeptides 
is due to the relatively native states of the proteins fractionated by 
the column. The membrane extract is composed of a series of very high 
molecular weight proteins, probably due to the association of the small 
molecular weight polypeptides into complexes of large molecular weight, 
which, therefore, elute very near the void volume of the column. Because 
of the large number of polypeptides which elute with the high molecular 
weight proteins, isolation was undertaken in SDS under reducing condi-
tions. The column elution profile in Fig. 22, shows that the column was 
separated by molecular weight as expected for a Sepharose 4B column. 
The column separation was run on three separate occasions with similar 
results; however, it was not possible to successfully resolve the 280, 
240, 220 x 10-3 molecular weight group of proteins by this method, The 
use of an SDS column is very helpful in separating proteins from plasma 
membranes which cannot be solubilized easily in aqueous non-detergent 
solutions. The method, however, has the disadvantage of disassociating 
subunits and at least partially denaturing the polypeptides involved. 
Separations of this type are, however, useful in getting material for 
chemical analysis. 
Isolated SA-180 Tumor Cell Plasma Membranes 
as Anticancer Immunizing Agents 
The interaction of the Ham/ICR outbred mouse with the SA-180 tumor 
was characterized. The life span of the host was determined following 
a challenge with viable SA-180 at concentrations of 102 through 106 
tumor cells per animal. The results (Fig, 23) show the per cent 
Figure 22. Sephaxose 4B in SDS Fractionation of the Solubilized SA-180 
Plasma Membrane 
Gels for the vaxious fractions axe shown above the peak. 
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Figure 23. The Mortality of Ham/ICR Mice Following Injection of Differ-
ent Cell Concentrations of SA-180 
Groups of Ham/ICR mice (15 animals/group) we~e challenged with 
viable SA-180 at concentrations of 102 through 10 cells. The number 
of animals dead from each group, plotted as the per cent cumulative 
mortality, is shown in a function of the time (hours) following tumor 
challenge. 
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cumulative mortality for each inoculation group (15 animals/group) 
plotted against the time of death after inoculation. Because the host 
in these studies is from outbred stock, the distribution of deaths 
within each challenge group is greater than that generally observed for 
inbred strains. From the cumulative mortality data a diagram plotting 
the mean survival time as a function of the cell inoculation concentra-
tion was constructed (Fig. 24). The results show that the mean survival 
time for the Ham/ICR host is a linear function of the inoculation density 
and, therefore, a good measure of the effects of immunization on tumor 
survival. The approximately 20 hours deviation in mean survival time 
resulting from a 102 tumor inoculation may result from the efforts of 
the host in combating tumor challenge by a small tumor burden. Calcula-
tions based on these data indicate that the SA-180 tumor cell has a 
generation time in this host of approximately 9 hours. Taking the 
generation time and the mean survival data at each tumor inoculation 
concentration, there should be about 1 x 1013 tumor cells in the host at 
death, Actual cell counts using animals near death from the various 
inoculation groups revealed that the tumor concentration at host death 
is about 9 x 1012 cells regardless of the inoculated tumor cell concen-
tration. 
Experiments were conducted to determine if the immunizing potential, 
i.e. those tumor associated antigens which are capable of eliciting an 
effective anti-SA-180 immune response, were retained in an active confor-
mation on the isolated plasma membrane. 
Test materials were administered i.p. at J injections/week for 2 
weeks. Controls in group (a) included 10 animals which received only 
saline and 10 animals which received human erythrocyte membranes (a 
Figure 24. Relationship of Tumor Inoculation Concentration to the Host 
Mean Survival Time 
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total of J,O mg membrane protein suspended in Hepes), Group (b) received 
a preparation of SA-180 plasma membrane (a total of 3,0 mg membrane 
protein suspended in Hepes). One week following the final injection of 
test material all animals were challenged (i.p.) with 1 x 104 viable 
SA-180 cells and the survival times, recorded for each animal, show the 
per cent of animals surviving in each group (Fig, 25), Control groups 
which had recieved Hepes or a non-tumor membrane protein (human erythro-
cyte ghosts) had a mean survival time of about 12 days. These results 
correlate well with our expected mean survival data of 11.5 days and 
show that the injection of a non-tumor membrane protein does not signif-
icantly stimulate the host. In group (b), (the mice which received the 
SA-180 membranes) the animals that died had a mean survival time of 15 
days, a substantial increase. Even more important, 40% or 4 out of the 
10 animals in this group completely survived the tunior challenge, Thirty 
days after the initial challenge, these survivors were again challenged 
with 104 viable SA-180 cells and all 4 animals have survived for approx-
imately 8 months. Those animals in group (b) which did not survive the 
initial challenge and whose mean survival time was 15 days were appar-
ently able to combat a major portion of the tumor challenge. Based on 
the inoculation concentration and mean survival time, these animals 
neutralized about 90% of the original 104 challenge dose. 
To further substantiate the anticancer immunizing potential of the 
isolated SA-180 plasma membrane, a different immunizing schedule and 
additional types of control material were used. The tumor membrane test 
group consisted of 10 animals which received the SA-180 plasma membranes 
prepared as described above at 0.4 mg protein on the first injection and 
0.8 mg on each of the remaining 5 injections. Controls were animals 
Figure 25, Per Cent of Animals Surviving At Various Times Following 
Injection of 104 SA-180 Cells 
Group (a) received Hepes, human erythrocyte membranes, (J,O mg pro-
tein total, i.p. J injections/week for 2 weeks), Group (b) received 
SA-180 membranes (J,0 mg protein total i.p. J injections/week for 2 
weeks), One week followi~g the final injection all animals were chal-
lenged (i.p,) with 1 x 104 viable SA-180 cells. 
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receiving Hepes, human erythrocyte membranes, types A, B or O, Ham/ICR 
mouse erythrocyte membranes or washed suspensions of in vitro grown fetal 
mouse cells (2 injections/week for 3 weeks). The control membranes were 
administered at 0.4 mg membrane protein on the first injection and 0.8 mg 
protein in each of the remaining 5 injections (4.4 mg total). The LM 
cells were administered at a concentration of 104 cells per injection 
for each of the 6 injections. This provides a total of 25 control 
animals receiving various types of membrane proteins as well as whole 
fetal mouse cells administered at one equivalent challenge dose per 
injection. One week following the final injection all animals were 
challenged with 104 viable SA-180 tumor cells and the host survival times 
recorded. Fig. 26, shows the per cent of animals surviving after tumor 
injection. As with the previous experiment, the control animals re-
ceiving saline, type A, B, or 0 human erythrocyte membranes, Ham/ICR 
mouse erythrocyte membranes or LM cells had a mean survival time of 
about 11.5 days. Those animals which died after receiving the SA-180 
plasma membranes had a mean survival time of about 13.5 days. However, 
?C!/o or 7 out of the 10 tumor membrane immunized animals survived the 
initial challenge. Thirty days following the initial challenge these 
animals were again challenged with 104 viable SA-180 cells and all 7 
lived an additional 90 days. At 90 days, the animals were sacrificed 
and necropsy revealed no evidence of tumor formation or gross abnormality 
of the major internal organs. These data indicate that the isolated 
SA-180 plasma membrane does retain the tumor associated antigens which 
are capable of eliciting an immune response in the host which was 
sufficient to neutralize most if not all viable S-180 cells following 
challenge. 
Figure 26. Per Cent of Animals Surviving at Various Times Following 
Injection of 104 SA-180 Cells 
Group (a) received Hepes, type A, B, or 0 human erythrocyte mem-
branes, Ham/ICR erythrocyte membranes (4.4 mg protein total, i p. 2 
injections/week for 3 weeks) or in vitro fetal mouse cells (104 cells/ 
injection, i.p. 2 injections/week for 3 weeks). Group (b) received 
SA-180 membranes (4.4 mg protein total, i.p. 2 injections/week for 3 
weeks). One week following the final injection all animals were chal-
lenged (i.p.) with 1 x 1o4 viable SA-180 cells. 
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Studies were conducted to determine the effectiveness of immuniza-
tion against challenges of different numbers of tumor cells, Control 
animals (40) were injected with Hepes (2 injections/week for 3 weeks) 
and 80 animals were injected with SA-180 membranes (2 injections/week 
for 3 weeks) with 4,4 mg total membrane protein as described above, 
Three days following the final membrane injection all animals including 
an additional control of 40 non-injected mice were divided into groups 
(10 animals/control group and 20 animals/membrane immunized group) and 
challenged with 102, 103, 104, or 105 viable SA-180 cells, Table VI 
shows the per cent survivors (surviving 30 days with no sign of tumor) 
and the mean survival time (MST) for each group, The results indicate 
that under these conditions the immune system is relatively successful 
in combating a tumor burden of 104 cells or smaller but unsuccessful 
when the tumor burden reaches 105 cells. These findings are in general 
agreement with experiments using other tumor host systems which show 
that the limits of tumor burden for successful immunotherapy are quite 
low (91,94). It should be noted that the interval from the last injec-
tion to challenge for Fig, 26, was 7 days compared to 3 days for Table 
VI which may explain the 20% difference in survivors at a 104 challenge. 
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TABLE VI 
TITRATION OF MEMBRANE IMMUNIZATION BY CHALLENGING MICE WITH 
SA-180 AT CONCENTRATIONS OF 102 TlffiOUGH 105 
Challenge Concentration 
Number of Viable SA-180 Injected Per Mouse 
102 10.3 104 105 
IMMUNIZING %Sa MSTb %Sa MSTb %Sa MSTb %Sa MSTb AGENT 
SA-180 
400±9 ,380±15 J10±8 280±8 Membranes 80 70 50 0 
Hepes 
Control 0 
Uninjected 
Control 0 
~--Per cent of animals surviving JO days following SA-180 
challenge. Control groups contained 10 animals per 
challenge concentration and membrane immunized groups 
contained 20 animals per challenge group. Animals were 
immunized with S-180 membrane (4.4 mg protein total, 2 
injections/week for .3 weeks) or Hepes and challenged .3 
days following the last injection. Uninjected controls 
received only the tumor challenge, 
bMST--Mean survival time (hours) for those animals in each 
group which died ±s.D. 
CHAPTER I.v 
DISCUSSION 
One of the more productive approaches to studying the structure of 
plasma membranes has been through studies of the chemical composition 
of isolated plasma membranes. A basic knowledge of the components and 
organization within the membrane is very important in any attempt at 
understanding the many functions which the plasma membranes performs. A 
prerequisite, however, to any such analysis is the isolation of plasma 
membranes which are free of other organelle contamination. A number of 
differing approaches have been used to obtain mammalian cell membranes. 
The tumor lines chosen for this study are all ascites lines, that is, 
they grow as single cells within the peritoneal cavity of the animal, 
although they are all capable of forming solid tumors, if injected 
subcutaneously. The single cells make the isolation easier since the 
problems created by cell-cell junctions are eliminated. The isolation 
procedures which were used yielded plasma membranes, in which 5'-
nucleotidase (a plasma membrane marker) was p:urified 14-38 fold, 
depending on the cell type. The membranes were contaminated by low 
levels of other subcellular organelle marker enzymes; however, their 
levels are at least as low as preparations by most other investigators. 
The analysis of polypeptides present in the membranes of the three 
tumors did not show any major similarities, however, the real informative 
value of the membrane patterns comes from studying how they change as 
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cells or membranes are manipulated under various controlled conditions. 
One method for understanding the organization of the membrane is to 
study the various methods used to isolate plasma membranes. The primary 
difference between membrane stabilization method and the microsomal 
method for the Sarcoma-180 is the presence of a group of high molecular 
weight proteins in the stabilized membranes. Several methods have been 
studied to determine what function these proteins serve. Shin and 
Carraway (15), showed that the presence of divalent cation in the homo-
genization medium allowed for the isolation of recognizable membrane 
sheets instead of microsomes. The microsomal method seems to work in 
a similar manner in that no stabilization reagent was present and the 
membranes were in the form of vesicles, The marked similarity in all 
the other bands lends credence to the idea that the plasma membrane 
fraction is in fact composed primarily of the Sarcoma-180 plasma membrane, 
since the two methods are based on different isolation properties. 
Application of the membrane stabilization method to the Sarcoma-180 in 
vitro grown line yielded plasma membranes which differed by the presence 
of glycoproteins on the surface membranes of in vitro grown Sarcoma-180 
tumor cells which are drastically reduced in the ascites form of the 
tumor. These well defined glycoprotein differences contrast sharply 
with the comparisons of membrane polypeptides, which are essentially 
the same for the two cell lines. A number of lines of evidence indicate 
that these are surface membrane associated glycoproteins, They are pre-
sent predominantly on the surface membrane fraction, which is distin-
guished morphologically and by enzyme markers from other cell membrane 
fractions. They are not readily removed from the membrane by extraction 
with 1 M salt or dilute EDTA solutions, although other proteins can be 
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removed from these membranes by these methods. The proteins are cleaved 
with release of glycopeptides and removed from the gel patterns by treat-
ment of the intact cells with trypsin, suggesting that they are on the 
surface of the cell. The glycoprotein could be iodinated by the lacto-
peroxidase surface labeling technique as first shown by Shin and 
Carraway (15) for the in vivo line. 
The function of these glycoproteins is unknown. Thei.r preferential 
association with in vitro grown cells suggests that they may be involved 
in the association of the cells with the substrate on which they grow:, 
This is further supported by the observation that their appearance in 
the isolated plasma membrane, and presumably, also in the cell is a 
function of the growth state of the cell, since they seem to disappear 
from the cell after it reaches confluency. The fact that cells are 
released from the substrate by trypsinization which cleaves the glyco-
proteins lends some credence to this idea. Further studies on condi-
tions which promote attachment or release of the cells are needed in 
order to evaluate the role of the glycoproteins in this phenomenen. 
Mild trypsinization of Sarcoma-180 tumor cells causes the loss of 
two different types of components from membrane electrophoretic profiles. 
One of these is the glycoproteins of the surface membranes and the other 
is a group of high molecular weight pqlypeptides associated with surface 
membranes of cells treated with zinc and other membrane "stabilizing" 
agents. Proteolytic cleavage of glycoprotein at cell surfaces was 
expected, since this has been demonstrated for a number of mammalian 
cell types by either release of glycopeptides or loss of the glycopro-
teins from electrophoretic profiles. The loss of the high molecular 
weight polypeptides was not expected. There are three explanations 
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that we consider most likely to explain this result: 1) The polypeptides 
are present at the exterior surface of the cell and cleaved by trypsin 
acting on the cell surface. 2) The polypeptides are associated with 
the interior surface of the membrane and cleaved by trypsin which passes 
into the cell. 3) The polypeptides are associated with the interior 
surface of the membrane and are released from this association as a 
result of membrane structural alterations that occur during proteolysis 
of cell surface components. We consider the last of these explanations 
most likely, since our circumstantial evidence (lactoperoxidase labeling) 
indicates that these components are not present on the c.ell exterior 
and since specific cleavage of these components by trypsin inside the 
cell would indicate a substrate specificity for the trypsin which 
appears unlikely (although not impossible), and which it does not exhibit 
with the isolated membranes. The third hypothesis is also attractive 
because it relates elements which may be involved in maintaining mem-
brane shape to events which occur at the cell surfaGe. 
Similar interactions have been proposed in the erythrocyte membrane 
between the surface glycoproteins and spectrin, which apparently plays 
a role in cell shape and membrane stabilization. There are noteworthy 
similarities between the properties of the polypeptides studied in 
this report and spectrin. Investigations of receptor mobility in mem-
branes have suggested the interaction of surface receptors with 
submembrane cytoskeletal elements. It is not necessary that these 
interactions be direct as has been proposed with the erythrocyte. 
Instead they could involve cooperative effects such as have been 
observed for hormone-membrane interactions. Since the strength and 
stability of the interactions may vary with the cell system and membrane 
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isolation procedure, the loss of these polypeptides with trypsinization 
may not necessarily be observed with other cell types. Further charac-
terization of the trypsinization process and of these polypeptides will 
be necessary to relate these observations to other cellular changes 
which occur with proteolysis. 
The correlation between the disappearance of the high molecular 
weight proteins and the shape change of the Sarcoma-180 lends support to 
the possibility that the proteins were involved in maintaining the shape 
of the cell· while it was attached to glass and while it was moving 
around the coverslip, as was seen when the cells were growing 12-24 hours 
after trypsinization was observed. Studies were, therefore, undertaken 
to gain an understanding of organization of these proteins with the 
plasma membrane. As shown earlier, these proteins are only found 
associated with the plasma membrane under certain conditions, which would 
yield whole envelopes or very large sheets of plasma membranes. The use 
of zn++ allowed isolation of the proteins with the membrane in a form 
where ~ large percentage could be extracted by low ionic strength buffers 
under ponditions which remove spectrin, a 240, 220 x 103 molecular 
! 
weignt doublet of the same apparent molecular weight as bands J-4 from 
'.:/ 
the Sarcoma-180. The extraction, however, also removed a large number 
of other proteins from the membrane at the same time. In one experiment 
it was possible to purify a small amount of bands J and 4 and subject it 
to amino acid analysis. The lack of hydroxyproline and hydroxylsine, 
which our amino acid system could detect shows that the band was not 
composed of collagen. When it was compared tp spectrin, a marginal 
relatedness could be determined. Further attempts to isolate large 
enough quantities for structural studies have been plagued by diffi-
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culties in removing the lower molecular weight contamination since under 
non-denaturing conditions these proteins have a very large molecular 
weight. Ammonium sulfate fractionation was successful in spearating a 
large amount of the lower molecular weight proteins from bands 1-4. 
Chromatography in SDS was also shown to separate the various proteins by 
molecular weight and will be helpful in obtaining proteins for chemical 
analysis of the type which was first performed on spectrin during the 
earlier stages of its study. 
Several investigators have achieved some success in using whole 
cell preparations as anticancer immunizing agBnts (86,91,92,108). We, 
therefore, became interested in whether the outside of the cell, i.e. 
the plasma membrane, could be used in a similar manner, The use of 
whole cells, even though inactivated, may pose many problems when applied 
to treatment protocols. The use of, isolated plasma membranes eliminates 
many of these problems. 
Our findings established that isolated SA-180 plasma membranes can 
be effective immunizing agents against homologous tumor. The admin-
istration of non-tumor membranes or in vitro grown fetal mouse cells 
showed no stimulation of the host's immune system in combating tumor 
challenge. Tunor cell membranes did enhance the survival time of the 
host and in many cases caused complete elimination of the challenge 
dose, This indicates that the reaction of the host to the tumor 
material results in a specific immune stimulation and not a non-specific 
response attributed to agents like BOG. 
The immunization of mice with SA-180 membranes was relatively 
successful with 50 to 70% of the animals surviving a 104 challenge, Use 
of combination immunotherapy, i.e. modified and unmodified membranes or 
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groups of membranes containing different modifications, may facilitate 
the rejection of even greater numbers of tumor cells. The use of mem-
branes as immunizing agents is highly desirable and represents a logical 
extension of current research efforts for the following reasons: a) The 
cell surface is that portion of the tumor cell which interacts with the 
host's immune system. b) Only homologous material contains the specific-
ity required for effective tumor rejection with the human situation 
probably requiring autochthonous material. c) Since the host's immune 
system has a finite response capability which has already been diminished 
by tumor burden, it should be presented with the maximum quantity of 
surface immunogen (cell membrane) while minimizing the addition of non-
surface antigen (DNA, RNA, enzymes, mitochondria, etc.). d) Administra-
tion of membranes minimizes the risk of infecting the host with viruses 
or other foreign agents which reside in cells both in vivo and in vitro 
and often remain active after the cells become non-viable. The findings 
described above indicate that the isolated plasma membrane may represent 
an important initial step toward the development of a more effective 
tumor specific immunotherapy agent. 
CHAPTER V 
SUMMARY 
Plasma membrane-enriched fractions were isolated from four cell 
types by homogenization in zinc solutions, followed by sucrose gradient 
centrifugation, or two-phase partition, and from the Sarcoma-180 ascites 
cell also by microsomal homogenization and separation on sucrose gradi-
ents. The Sarcoma-180 tumor cells grown in vitro in cell culture or in 
vivo as an ascites form in mice were isolated by the Zn++ homogenization 
method, 5'-Nucleotidase was assayed as a plasma membrane marker and was 
found to be 18-23 fold increased compared to homogenates. Membranes 
from both cell lines appeared as ruptured envelopes or large fragments, 
Membranes were also isolated from the ascites form by a microsomal 
homogenization followed by sucrose density gradient centrifugation. The 
plasma membrane enriched fraction showed a 19 fold increase in 5'-
nucleotidase with some glucose 6-phosphatase contamination, an endoplas~ 
mic reticulum marker. 
Application of the Zn++ homogenization prodecure to the mouse 
L-1210 acute lymphoblastic leukemia yielded a plasma membrane fraction 
with a 34 fold increase in 5'-nucleotidase. Application to the 13762 
MAT, derived from the 13762 rat mammary adenocarcinoma yielded a frac-
tion with a 13.8 fold increase in 5°-nucleotidase. The protein and 
glycoprotein components of the plasma membranes are shown by coomassie 
blue and periodate-Schiff (PAS) staining of dodecyl sulfate acrylamide 
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gels of isolated plasma membrane fractions from the cell lines. Patterns 
for the 13762 MAT and L-1210 show 19 major proteins and 5 (13762 MAT) 
and 4 (L-1210) glycoproteins for the cell plasma membranes, ranging from 
500,000+ to 25,000 molecular weight, The Sarcoma-180 lines show 15 major 
proteins and 3 glycoproteins. There are significant differences between 
membranes isolated by the stabilization and microsomal methods in only 
three protein bands. + The 500,000 , 280,000 and 237,000 molecular weight 
bands are missing in the microsomal isolation technique which yields 
very small vesicles, 
A comparison of the plasma membranes from the two Sarcoma lines 
reveals no major differences in membrane proteins, but the cells grown 
in culture show the presence of a set of surface membrane glycoproteins 
which are absent or markedly decreased in the ascites form. Conversely, 
the ascites form has a glycoprotein which is not evident in the cells in 
culture. These glycoproteins can be demonstrated both by PAS staining 
and lactoperoxidase labeling. The glycoprotein differences may be 
related to the ability of the cells to interact with each other or a 
substratum. 
The effect of mild proteolysis in the Sarcoma-180 cells was investi-
gated using low concentrations of trypsin (5mg/ml). Morphological 
changes occuring in the cultured form attached to glass show a change 
from a fibroblastic shape to a rounded form over a 30 minute period 
during and following a 15 minute exposure to trypsin. To study the 
molecular basis for this change, plasma membranes were isolated from 
control and 15 minute trypsinized cells and subjected to electrophoresis. 
As expected, the surface glycoproteins were removed from the profiles. 
However, a set of high molecular weight proteins were also lost from 
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the profile. The same results were obtained from both cell lines. 
These proteins appear to be important in maintaining cell shape and may 
represent a cell cytoskeleton. Because the high molecular weight pro-
teins affected by trypsin were similar to spectrin, a protein doublet of 
the red blood cell membrane believed to be important in maintaining 
shape in that cell, comparisons were made between the cells. The 
Sarcoma~180 ascites tumor plasma membrane high molecular weight doublet 
protein can be extracted by low ionic strength and partially purified by 
column chromatography in dodecyl sulfate, or partially purified in its 
native form on a G-200 column. The protein appears to be similar to 
spectrin in its behavior. 
Isolated Sarcoma-180 ascites plasma membranes have been investigated 
as potential anticancer agents. Mice were immunized with Sarcoma-180 
plasma membranes, and then challenged with 102-105 viable tumor cells. 
Up to ?CJ!, of the mice were able to combat 104 cells and survive 30 days, 
at which time they were rechallenged with 1 x 104 cells and-all survived 
an additional 60 days. Control animals immunized with saline, mouse or 
human red blood cell membranes, or fetal mouse cells were afforded no 
protection. This method may represent a starting point for a possible 
treatment method. 
A SELECTED BIBLIOGRAPHY 
(1) Burger, M. M. (1973) Fed. Proc. ,2g_, 91. 
(2) Loewenstein, W. R. (1973) Fed. Proc. ,2g_, 60. 
(3) Carraway, K. L., Kobylka, D. and Triplett, R. B. (1971) Biochim. 
Biophys. Acta 241, 934. 
(4) Bender, W.W., Garan, H. and Berg, H. C. (1971) J. Mol. Biol . ..2§, 
783. 
(5) Bretscher, M. S. (1971) J, Mol. Biol . ..2§, 775. 
(6) Phillips, D. R, and Morrison, M. (1971) FEBS Letters 18, 95. 
(7) Triplett, R. B. and Carraway, K. L. (1972) Biochemistry 11, 2897, 
(8) Steck, T. L, and Wallach, D, F. H. (1970) Methods in Cancer Res. 
_2, 93. 
(9) Wallach, D. F. H., and Kamat, V. B. (1966) Methods in Enzym. ~' 
164. 
( 10) 
(11) 
(12) 
( 13) 
Warren, L,, Glick, M. C., 
68, 269. 
Mccollester, D. L. (1970) 
Roizman, B. , and Spear, P. 
Jamieson, G. A., and Groh, 
and Nass, M. K. (1966) J. Cell. Physiol. 
Cancer Res. 2.Q, 2832. 
G. ( 1971) Science 171, 298. 
N. ( 1971) Anal. Biochem. ~' 259. 
(14) Truffa-Bachi, P., and Wofsy, L. (1970) Proc. Natl. Acad. Sci. 66, 
685. 
(15) Shin, B. C., and Carraway, K. L. (1973) Biochem, Biophys. Acta 12.Q. 
(16) Korn, E. D. (1969) Fed. Proc. 28, 6. 
(17) Wallach, D. F. H. (1967) in "The Specificity of Celi Surfaces", 
D. B, Davis and L. Warren, Eds., Prentice-Hall Englewood 
Cliffs, New Jersey. 
(18) Emmelot, P., Bos, C. J., Benedetti, E. L., and Rumke, P. (1964) 
Biochem. Biophys. Acta 2Q, 126. 
112 
113 
(19) Hagopian, A., Bosmann, H.B., and Eylar, E. H. (1968) Arch Biochem. 
Biophys. 128, 387. 
(20) Graham, J.M., Higgins, J. A., and Green, C. (1968) Biochim. 
Biophys. Acta 12.Q, 303, 
(21) Boone, C. W., Ford, L. E., Bond, H. E., Stuart, D. C., and Lorenz, 
D. (1969) J. Cell. Biol. 41, 378. 
(22) Maddy, A. H. (1964) Biochim Biophys. Acta 88, 448. 
(23) Berg, H. C. (1969) Biochim. Biophys, Acta 183, 65. 
(24) Phillips, D.R., and Morrison, M. (1970) Biochem. Biophys, Res. 
Commun. 40, 284. 
(25) Marinetti, G. V., and Gray, G. M. (1967) Biochim. Biophys. Acta 
.fil, 580. 
(26) Singer, S. J., and Nicolson, G. L. (1974) Science ..!.12, 720. 
(27) Taylor, R. B., Duffus, W. P.H., Raff, M. C., and de Petris, S. (1971) Nature New Biol. ~' 225, 
(28) Frye, C. D., and Edidin, M. (1970) J. Cell. Sci.~' 313. 
(29) Rosenblith, J. z., Ukena, T. E. H. H., Berlin, R. D., and 
Karnovsky, M. J. (1973) Proc. Nat. Acad. Sci., U.S.A. 70, 
1625. 
(30) Nicolson, G. L., and Painter, R. G. (1973) J. Cell. Biol. j2, 395, 
(31) Singer, S. J. (1974) Adv. in Immunol. 1.2.1 1. 
(32) Cuatrecasas, P. (1969) Proc. Natl. Acad. Sci., U.S.A.~' 450. 
(33) Abercrombie, M., and Ambrose, E. J. (1962) Cancer Res. 22, 525. 
(34) Revel, J. P. and Ito, S. (1967) in "The Specificity of Cell Sur-
(35) 
faces", B. D. Davis and J. Warren, eds., Prentice-Hall, 
Englewood Cliffs, New Jersey, p, 211. 
Winzler, R. J., Harris, E. D., Pekas, D. J., Johnson, C. A., and 
Weber, P. (1967) Biochemistry£, 2195, 
(36) Langley, O. K., and Ambrose, E. J. (1967) Biochem J, 102, 367. 
(37) Pricer, W. E., Jr, and Ashwell, G, (1971) J, Biol. Chem. 246, 
4825. 
(38) Cuatrecasas, P., and Illiano, G. (1971) J. Biol. Chem. 246, 4938. 
(39) Lilien, J.E., Chiller, J. M,, and Weigle, W. O. (1973) J. Exp. 
Med., 138, 148. 
114 
(40) Hakamori, S. I., and Murakami, W. T. (1968) Proc. Natl, Acad. Sci. 
U.S.A. 60, 459, 
(41) Bosmann, H, B. (1969) Expl. Cell. Res, _2t, 217, 
(42) Grimes, W. J, (1970) Biochemistry 2, 5083, 
(43) Burger, M. M. (1969) Proc. Natl. Acad, Sci., U.S.A. 62, 994, 
(44) Inbar, M., Ben-Bassat, H., and Sachs, L, (1971) J, Membranes Biol • 
.§, 195, 
(45) Burger, M. M., and Nooman, K. D. (1970) Nature 228, 512. 
(46) Nicolson, G. L. (1971) Nature~' 244. 
(47) Warren, L,, Fuber, J, P., and Buck, C, A. (1972) Proc. Nat, Acad. 
Sci., U.S.A • ..§2., 1838, 
(48) Kobylka, D., Khettry, A., Shin, B. C., and Carraway, K. L. (1972) 
Arch. Biochem. Biophys. 148, 475, 
(49) Marton, L. S. G., and Garvin, J, E. (1973) Biochem. Biophys, Res. 
Commun, jg, 1457. 
(50) Fairbanks, G., Steck, T. L., and Wallach, D. F. H. (1971) Bio-
chemistry 10, 2606. 
(51) Rosenberg, S. A., and Guidotti, C. (1969) J, Biol. Chem. 244, 5118, 
(52) Gwynne, J, T., and Tanford, C. (1970) J, Biol. Chem. 245, 3259, 
(53) Marchesi, V. T., and Steers, E., Jr. (1968) Science 1..22.' 203. 
(54) Greenberg, C. S., and Glick, M. C. (1972) Biochemistry 11, 3680. 
(55) Naville, D. M., Jr,, and Clossmann, H. (1971) J. Biol. Chem. 246, 
6335, -
(56) Bailey, A. J,, Peach, C. M., and Fowler, L. J, (1970) Biochem. J, 
111, 815. 
(57) Lorand, L., Chenoweth, D., and Domanik, R. A. (1969) Biochem, 
Biophy. Res. Commun. 27, 219. 
(58) Birckbichler, P. J,, Dowben, R. M., Matacic, S., and Loewy, A, G. (1973) Biochim. Biophys. Acta 291, 149. 
(59) Dunn, M, J., and Maddy, A. H. (1973) FEBS Letters J.§., 79, 
(60) Clarke, M. (1971) Biochem. Biophys. Res. Commun. ~. 1063, 
(61) Tillack, T. W., Marchesi, s. L,, Marchesi, V. T., and Steers, E., 
Jr. (1970) Biochim. Biophys. Acta 200, 125, 
115 
(62) Trayer, H. R., Nezaki, Y., Reynolds, J, A., and Tanford, C. (1917) 
J, Biol. Chem. 246, 4485, 
(63) Hulla, F. W., and Gratzer, W. B. (1972) FEES Letters £2, 275. 
(64) Guidotti, G. (1972) Arch. Interm. Med • .,!g2_, 194. 
(65) Rosenthal, A. S., Kregenow, F. M. and Moses, H. L, (1970) Biochim. 
Biophys. Acta 196, 254. 
(66) Guthrow, C. E., Jr,, Allen, J.E., and Rasmussen, H. (1972) J, 
Biol. Chem. 247, 8145. 
(67) Juliano, R. L., Kinelberg, H.K., and Papahadjopoulos, D. (1971) 
Biochim. Biophys, Acta 241, 894. 
(68) Hughes, R. C. (1973) Frog. in Biophys. and Molec. Biol. 26, 191. 
(69) Hynes, R. O. (1974) Cell 1, 147. 
(70) Burger, M. M. (1973) Fed. Proc. Jg, 91. 
(71) Buck, C, A., Glick, M. C., and Warren, L. (1970) Biochemistry 9, 
4567. 
(72) Vaheri, A., and Ruoslahti, E. (1974) Int. J, Cancer 1], 579, 
(73) Hogg, N. M. (1974) Proc. Nat. Acad. Sci., U.S.A. 71, 489. 
(74) Hynes, R. O. (1973) Proc. Nat. Acad. Sci., U.S.A. 70, 3170. 
(75) Gahmberg, J., and Hakomori, S.--I. (1973) Proc. Nat. Acad. Sci. 
U.S.A. 1Q, 3327. 
(76) Shin, B. C., and Carraway, K. L, (1974) Biochim, Biophys. Acta 
1±.21 141. 
(77) Hellstrom, K. E., and Moller, G. (1965) Progr. Allergy 2, 158. 
(78) Klein, G. (1971) Advance Immunol. 14, 187. 
(79) Alexander, P. (1968) Frogs, Exp. Tumor Res. 10, 23. 
(80) Hellstrom, K. E., and Hellstrom, I. (1971) in "Advances in immu-
nology11, F. J, Dixon and H. G. Kunkel, eds., Academic Press, 
New York, p. 209. 
(81) Coggin, J. H., Jr., and Anderson, N. G. (1974) in "Advances in 
Cancer Res.", G. Klein and S. Weinhouse, eds., Academic 
Press, New York, p. 105. 
(82) Klein, G., Sjogren, J. O., Klein E. and Hellstrom, K. E. (1960) 
Cancer Res. 20, 1561. 
116 
(8J) Smith, R. T,, and Landy, M. (1971) "Immuno Surveillance", Academic 
Press, New York. 
(84) Cerottine, J., and Brunner, K. T. (1974) in "Advances in Immunol.:.. 
ogy" , F. J. Dixon and H. G. Kumkel, eds. , Academic Press, 
New York, p. 67. 
(85) Herberman, R. B. (1974) in "Advances in Cancer Res.", G. Klein 
and S. Weinhouse, eds., Academic Press, New York, p. 207. 
(86) 
(87) 
(88) 
(89) 
Simmons, R. L •, Rios, A. 
Newcomb, E. w., Weksler, 
Faraci, R. P. and Schour, 
Atkinson, P., and Davies, 
( 1972) Ann. Surg. 176, 188. 
M. E. (1974) Cancer Res. 1±, 100. 
L. ( 1974) Science 185, 68. 
I. ( 1974) Experientia 2.Q, 427. 
(90) Bekesi, J. G., Arneault, G., Walter, L., and Holland, J. G. (1972) 
J. Nat. Can. Inst. !±2_, 107. 
(91) 
(92) 
Kollmorgen, G. M., Erwin, D. N., Killion, J. J., and Sansing, w. 
A. (197J) Ann. Oklahoma Acad. Sci. pp. 25. 
Prager, M. D., Derr, I., Swann, A., and Cotropia, J. (1971) 
Cancer Res. 11, 1488. 
(9J) Hakala, T. R., and Lange, P. H. (1974) Science 184, 795. 
(94) Hersh, E. M., Gutterman, T. U., and Maulight, G. (197J) "Immunol-
ogy of Cancer in Man", C. C. Thomas ed. , Springfield, · 
Illinois. 
(95) Mathe, C., and Weiner, R. (1974) "Recent Results in Cancer 
Research", Springer-Verlag, New York. 
(96) Abramoff, P. and La Via, M. F. (1970) "Biology of the Immune 
Responsevv, McGraw-Hill, New York, p. 272. 
(97) Shipman, C. (1969) P.S.E.B.M. 130, J05. 
(98) Iwakata, S. and Grace, J. T., Jr. (1964) N. Y. Jour. of Med. 64, 
2279. 
(99) Morgan, J. F., Martin, H. J., and Parker, R. C. (1950) Proc. Soc. 
Exp. Biol. and Med. 12• 1. 
(100) Brunette, D. M. and Till, J. E. (1971) J, Membrane Biol. j, 215. 
(101) Spackman, D. H., Stein, W. H., and Moore, S. (1958) Anal. Chem~ 
2.Q, 119. 
(102) Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 12], 265. 
(103) Lazarus, L, H. and Chou, S.--C. (1972) Anal. Biochem. !±2,, 557, 
(104) Morre', D. J, (1971) Methods in Enzymol, 22, 130, 
(105) Goldfischer, S,, Essener, E., and Nivikoff, A. B. (1964) J, 
Histochem. Cytochem. 12, 72. 
(106) Bray, G. A. (1960) Anal. Biochem. 1P 279, 
(107) Marchalonis, J, J., and Weltman, J, K. (1971) Comp. Biochem. 
Physiol. J8B, 609, 
117 
(108) Bekesi, J, G., St-Arneault, G., and Holland, J, F. (1971) Cancer 
Res, 31, 2130, 
~ 
VITA 
John William Huggins 
Candidate for the Degree of 
Doctor of Philosophy 
Thesis: THE ISOLATION, CHARACTERIZATION, AND UTILIZATION OF PLASMA 
MEMBRANES FROM TUMOR CELLS 
Major Field: Biochemistry 
Biographical: 
Personal Data: Born in Tulsa, Oklahoma, January 27, 1948, the 
son of Mr. and Mrs. O. R. Huggins. 
Education: Graduated from Nathen Hale High School, Tulsa, 
Oklahoma, in May 1966; received Bachelor of Science degree 
in Biochemistry from Oklahoma State University in 1971; 
completed requirements for the Doctor of Philosophy degree 
at Oklahoma State University in May, 1975, 
Professional Experience: Research Assistant, Department of 
Biochemistry, Oklahoma State University, January ,1971 
to present. 
